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BACKGROUND: Maternal factors, including increasing childbearing age and various life-style factors, are associated with poorer short-
and long-term outcomes for children, whereas knowledge of paternal parameters is limited. Recently, increasing paternal age has been
associated with adverse obstetric outcomes, birth defects, autism spectrum disorders and schizophrenia in children.
OBJECTIVE AND RATIONALE: The aim of this systematic review is to describe the influence of paternal factors on adverse short-
and long-term child outcomes.
SEARCH METHODS: PubMed, Embase and Cochrane databases up to January 2017 were searched. Paternal factors examined included
paternal age and life-style factors such as body mass index (BMI), adiposity and cigarette smoking. The outcome variables assessed were
short-term outcomes such as preterm birth, low birth weight, small for gestational age (SGA), stillbirth, birth defects and chromosomal
anomalies. Long-term outcome variables included mortality, cancers, psychiatric diseases/disorders and metabolic diseases. The systematic
review follows PRISMA guidelines. Relevant meta-analyses were performed.
OUTCOMES: The search included 14 371 articles out of which 238 met the inclusion criteria, and 81 were included in quantitative syn-
thesis (meta-analyses). Paternal age and paternal life-style factors have an association with adverse outcome in offspring. This is particularly
evident for psychiatric disorders such as autism, autism spectrum disorders and schizophrenia, but an association is also found with still-
birth, any birth defects, orofacial clefts and trisomy 21. Paternal height, but not BMI, is associated with birth weight in offspring while pater-
nal BMI is associated with BMI, weight and/or body fat in childhood. Paternal smoking is found to be associated with an increase in SGA,
birth defects such as congenital heart defects, and orofacial clefts, cancers, brain tumours and acute lymphoblastic leukaemia. These asso-
ciations are significant although moderate in size, with most pooled estimates between 1.05 and 1.5, and none exceeding 2.0.
WIDER IMPLICATIONS: Although the increased risks of adverse outcome in offspring associated with paternal factors and identified in
this report represent serious health effects, the magnitude of these effects seems modest.
Key words: paternal age / BMI / smoking / perinatal outcome / birth defects / autism / schizophrenia / cancer / mortality
Introduction
There is evidence that reproductive failures originate during the peri-
conceptional period and that such failures are influenced by the age
and the life-style of the partners (Sinclair and Watkins, 2013;
Steegers-Theunissen et al., 2013). Maternal factors, such as the
woman’s childbearing age and various life-style factors, are associated
with poorer short- and long-term outcomes in the offspring
(Jacobsson et al., 2004; Wennberg et al., 2016) whereas knowledge
of the influence of paternal factors is limited (Soubry et al., 2014).
Over the last few decades, the childbearing age of the mother has
increased worldwide from the early 20s to the early 30s (National
Institute for Health and Welfare. Nordic perinatal statistics, 2014.
Helsinki, Finland). This has increased the focus on the influence of
maternal age on the short and long-term health of mothers and children
(Jacobsson et al., 2004). However, there has been less focus on the age
of the male partner, which has been rising in parallel with maternal
childbearing age (Khandwala et al., 2017). Recently, paternal age has
been associated with a wide range of adverse health effects in offspring,
including both autism spectrum disorders (ASDs) and schizophrenia
(Reichenberg et al., 2006). The mechanisms explaining these associa-
tions remain unclear (Frans et al., 2015). As a man ages, the number of
de novo mutations in his sperm increases along with the chance that a
child might carry a deleterious mutation leading to possible diseases
(Kong et al., 2012). Recently, a novel mechanism has been suggested
which may contribute to the association with paternal age, the process
known as ‘selfish spermatogonial selection’ (Goriely and Wilkie, 2012)
where rare spermatogonial cells bearing mutations are positively
selected leading to their progressive clonal expansion. This process
seems to affect all men, especially as they age.
Furthermore, advanced paternal age has been linked to aneuploidy in
autosomes and sex-chromosomes (Lowe et al., 2001; Zhu et al., 2005b)
and epigenetic alterations have been proposed as mechanisms by which
modifications in gene expression can be transmitted to the offspring
(Perrin et al., 2007). In addition, older fathers may represent a non-
typical male population, as both higher and lower socio-economic sta-
tuses are overrepresented among older fathers (Nilsen et al., 2013).
Whereas, it is well known that maternal smoking, alcohol con-
sumption and high BMI are associated with poorer short- and long-
term outcomes for the children, knowledge of the effects of paternal
life-style factors is limited. Malnutrition may impair several metabolic
pathways (Steegers-Theunissen et al., 2013), and cigarette smoking
can cause DNA or chromosomal damage in human germinal cells,
including spermatozoa (Zenzes, 2000). Because ejaculated sperm has
minimal, if any, repair capacity it is likely that these changes can be
transmitted to the offspring.
The aim of this systematic review was to assess the influence of
periconceptional paternal factors on adverse short and long-term
child outcomes. These include preterm birth (PTB), low birth weight
(LBW), small for gestational age (SGA), birth defects, chromosomal
anomalies, psychiatric disorders such as schizophrenia and autism dis-
orders, mortality, impaired neurodevelopment and cognitive func-
tions, and cardio-metabolic functions. We have included the following
paternal exposure factors: age, BMI, height, and/or weight and cigarette
smoking.
Methods
We searched the PubMed, Cochrane and Embase databases up to
January 2017. Exposures were periconceptional paternal age, paternal
smoking and paternal BMI, height, and/or weight. Short-term obstetric
outcomes we looked for included PTB, birth weight (BW), LBW, SGA,
stillbirth and neonatal death (NND). Further significant outcomes were
children with birth defects in general, and selected birth defects i.e.
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orofacial clefts, gastroschisis, congenital heart defects (CHDs), spina bifida
and trisomy 21. Long-term outcomes included childhood mortality and
morbidity e.g. leukaemia and other malignancies, childhood body weight
and BMI, cardio-metabolic disorders, autism/ASD, schizophrenia, other
psychiatric disorders and impaired cognitive function. Several of these
outcomes when appropriate were used for meta-analysis.
Systematic search for evidence
The terms used in the searches are listed below:
(‘Paternal Age’[Mesh]) OR (‘Paternal Exposure’[Mesh]) AND (‘Congenital
Abnormalities’)[Mesh] OR congenital malformat*[tiab] OR congenital abnor-
mal*[tiab] OR birth defect*[tiab] OR ‘Birth Weight’[Mesh] OR birth weight
[tiab] OR birth weight[tiab] OR premature birth[tiab] OR premature deliv-
ery[tiab] OR ‘Perinatal Mortality’[Mesh] OR ‘Perinatal Death’[Mesh] OR
perinatal outcome*[tiab] OR ‘Stillbirth’[Mesh] OR ‘Live Birth’[Mesh] OR still-
birth[tiab] OR live birth*[tiab] OR outcome[tiab] OR outcomes[tiab] OR
gestational age[tiab] OR children[tiab] OR child[tiab] OR ‘Autism Spectrum
Disorder’[Mesh] OR ‘Autistic Disorder’[Mesh] OR ‘Schizophrenia’[Mesh]
OR autism[tiab] OR autistic[tiab] OR schizophrenia[tiab]) NOT (animals
[mh] AND humans[mh])) NOT (‘News’[Publication Type] OR ‘Newspaper
Article’[Publication Type]).
We also manually searched reference lists of identified articles for add-
itional references. Guidelines for meta-analysis and systematic reviews of
observational studies were followed (Stroup et al., 2000). The literature
search was performed by two researchers (C.B. and U.B.W.) and one
librarian. Screening of abstracts and of full papers for inclusion was done
by pairs of reviewers (C.B. and U.B.W., A.P. and A.L., N.O. and L.B.R.,
V.S.A. and H.L.). Differences of opinion in the team were solved by dis-
cussion until consensus was achieved.
Inclusion and exclusion of studies
Original studies published in English and the Nordic languages were
included. In the case of double publication, the latest study was included.
Studies with a control group and case series with more than 100 patients
were included. Concerning very rare diseases, studies with fewer cases
were also included. Studies published only as abstracts and case reports
were excluded. Studies dealing with paternal age were excluded if they
did not adjust for maternal age. Systematic reviews without meta-
analyses were excluded.
Definitions
PTB was defined as gestational age <37 weeks, very PTB (VPTB) as a
gestational age <32 weeks. LBW was defined as BW <2500 g and very
LBW (VLBW) as a BW <1500 g. SGA/intrauterine growth retardation
(IUGR), stillbirth and birth defects were defined by each author.
Appraisal of certainty of evidence
The methodological quality of the studies, in terms of risk of bias, was
assessed by pairs of reviewers. We used the tools developed by SBU
(Swedish Agency for Health Technology Assessment and Assessment of
Social Services) (www.sbu.se/sv/Evidensbaserad-vard/Utvardering-av-metoder-
i-halso-och-sjukvarden–En-handbok/) for assessing original articles, which
grade articles as being of low, moderate and high quality. For systematic
reviews we used AMSTAR (AMSTAR: Assessing the Methodological
Quality of Systematic Reviews Systematic reviews, cohort and case con-
trol studies, but not case series, were assessed for methodological qual-
ity. For certainty of evidence we used the Grading of Recommendations
Assessment, Development and Evaluation (GRADE) system (Guyatt
et al., 2008).
The GRADE system evaluates the following variables for all studies,
both combined and per outcome: Design, study limitations, consistency,
directness, precision, publication bias, magnitude of effect, relative effect
and absolute effect. Certainty levels are divided into high, moderate, low
and very low certainty. Certainty levels are based on our confidence in
the effect estimate, which in turn is based on the number of studies,
design of studies, consistency of associations between studies, study lim-
itations, directness, precision, publication bias, effect size, and relative
and absolute effect.
The certainty levels are; very confident = high certainty, moderately
confident = moderate certainty, limited confidence = low certainty and
very little confidence = very low certainty. If conclusions are based on
RCTs, GRADE starts at high certainty level (level 4) but can be down-
graded, while if conclusions are based on observational studies GRADE
starts at low certainty level (level 2) but might be upgraded (or down-
graded). If conclusions were based on case series, no assessment of
GRADE was performed.
Statistics
Outcomes are given in odds ratio (OR), adjusted odds ratio (AOR),
adjusted prevalence odds ratio (APOR), hazard ratio (HR), adjusted haz-
ard ratio (AHR), RR (relative risk), adjusted relative risk, adjusted preva-
lence ratio (APR), adjusted incidence rate ratio (AIRR) or adjusted
mortality rate ratio (AMRR) with 95% CI. A few studies used mean stan-
dardized BW and standardized regression coefficient (Beta).
Meta-analyses were performed despite significant heterogeneity in ref-
erence groups for paternal age and despite the fact that outcomes were
given in AOR, AHR or APR. A random effects meta-analysis using the
DerSimonian and Laird method, with the estimate of heterogeneity being
taken from the Mantel-Haenszel model, was used in the analysis (com-
mand metan in Stata 15: StataCorp LLC, TX, USA).
Results
The search strategy identified a total of 14 371 articles, of which 238
were selected for inclusion in the systematic review and 81 for inclu-
sion in quantitative synthesis (meta-analysis) (Fig. 1, PRISMA Flow
chart)
Among the studies included were 10 meta-analyses, 127 cohort
studies, 96 case control studies and 5 case series (Supplementary
Tables SI–III). Excluded studies, with reasons for exclusion, are pre-
sented in Supplementary Table SIV.
A quality assessment of the cohort and case control studies
included is presented in Supplementary Tables SV–VII and for system-
atic reviews in Supplementary Table SVIII. Of the selected cohort and
case control studies, 35 articles were of high quality, 103 were of
moderate quality and 85 of low quality. Of the systematic reviews
included, nine were of medium quality and one was of low quality.
Paternal age at childbirth and short-term
outcomes for offspring
Obstetric outcomes
PTB and very PTB. Nine cohort studies, comprising more than 10 mil-
lion births in total, reported on PTB or VPTB or both (Supplementary
Table SI, Table I). Six cohort studies were of high quality and three of
medium quality. Three studies (Abel et al., 2002; Zhu et al., 2005a;
Astolfi et al., 2006) found a small but significantly increased risk of PTB
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associated with advanced paternal age. Low paternal age (<20 or <25
years) was associated with a higher risk of PTB in four studies (Abel
et al., 2002; Chen et al., 2008; Alio et al., 2012; Astolfi et al., 2006).
Our meta-analysis including eight of the studies showed a pooled AOR
estimate of 1.02 (95% CI 1.00–1.05) of PTB in older versus younger
(reference groups varied between 20 and 34 years) fathers (the forest
plot is shown in Fig. 2). In the Danish study by Zhu et al. (2005a) the
risk of VPTB in older fathers was increased, but not in the US study by
Basso and Wilcox (2006).
Conclusion: There may be little or no difference in the rate of
PTB between older and younger fathers. Low certainty of evidence
(GRADE⊕⊕○○).
Low BW and very low BW. Nine cohort studies (three high, three
medium and three low quality) comprising almost 6 million births
assessed LBW, two of them also VLBW (Abel et al., 2002: Chen
et al., 2008) (Supplementary Table SI, Table I).
We performed a meta-analysis with LBW as outcome. We
included six studies, and found a pooled estimate of 1.00 (95% CI
0.97–1.03) for LBW in older versus younger (reference groups varied
between 20 and 34 years) fathers (Fig. 3). Low paternal age (<20 or
<25 years) was associated with a higher risk of LBW in three studies
(Abel et al., 2002; Chen et al., 2008; Alio et al., 2012).
None of the studies assessing the risk of VLBW in older fathers
found an increased risk.
Conclusion: There may be little or no difference in the rate of
LBW between older and younger fathers. Low certainty of evidence
(GRADE⊕⊕○○).
Small for gestational age. Five cohort studies (two high, two medium
and one low quality), comprising almost 4 million births, found no
association between infants born SGA and increased paternal age
(Supplementary Table SI, Table I).
Conclusion: There may be little or no difference in the rate of
SGA between older and younger fathers. Low certainty of evidence
(GRADE⊕⊕○○).
Stillbirth/neonatal mortality. Four cohort studies, comprising between
23 821 and 3 610 647 births, three of high quality and one of medium
quality, reported stillbirths (Supplementary Table SI, Table I. In an
analysis of more than 3 million births, Astolfi et al. (2004) (high qual-
ity) found in an Italian cohort study a significantly increased risk of
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Figure 1 PRISMA flow diagram for a systematic review and meta-analysis on the effect of paternal factors on perinatal and paediatric outcomes.
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Table I Studies on human paternal age and obstetric outcomes identified in a systematic review of the literature on the effect of paternal factors on perinatal
and paediatric outcomes.
Author, year,
country
Study design Number of
pregnancies, births or
children
Result Outcomes
Comments
Adjustments
Study quality
Outcomes (risk estimates) Reference group/
controls
Original articles n = 16
Abel et al. (2002),
USA
Cohort study 155 903 births Paternal age < 20 years:
PTB:
AOR 1.24 (1.02–1.52)
LBW:
AOR 1.28 (1.02–1.61)
Paternal age 21–25 years PTB and LBW:
Significantly higher risk for low paternal age. No
other significances.
Adjusted for maternal age, socio-economic
status, infant gender and race
High
Alio et al. (2012),
USA
Cohort study 755 334 singletons LBW, PTB (33–37 weeks), VPTB
(<33 weeks):
Paternal age < 20, 20–24 years:
AORs 1.10 to 1.31 (1.07 to 1.41)*
>45 years:
AORs 1.13 to 1.19 (1.05 to 1.44)*
SGA:
<20 years:
AORs 1.18 (1.13–1.24)
20–24 years: 1.12 (1.10–1.15)
Stillbirth (≥20 weeks):
40–45 years: AOR 1.24
(1.04–1.47)
>45 years: 1.33 (1.02–1.77)
*lowest and highest 95% CI
Paternal age 25–29 years LBW, PTB, VPTB:
U-shaped risk with significantly higher risk for
low and high paternal age.
SGA:
Significantly higher risk for younger fathers.
Stillbirth:
Significantly higher risk for older fathers.
Adjusted for maternal age, race, education,
marital status, years of birth, maternal
complications, prenatal care, smoking and
alcohol
High
Astolfi et al. (2004),
Italy
Cohort study 3 619 647 births Stillbirth:
Paternal age ≥ 40 years, maternal
age <35 years, high education
OR 1.12 (1.00–1.25)
Paternal age ≥40 years, maternal
age <35 years, low education:
OR 1.29 (1.17–1.43)
Paternal age <40 years,
maternal age <35 years
Stillbirth:
Significantly higher risk for high paternal age with
low parental education Stratified for maternal
age (<35 and ≥35 years) and parental education
High
Astolfi et al. (2006),
Italy
Cohort study 1 510 893 births Paternal age <25 years:
PTB:
OR 1.19 (1.12–1.26)
VPTB:
1.36 (1.19–1.56)
PTB:
35–39, 40–44, 45–49 years
ORs 1.01 to 1.36 (1.08 to 1.56)*
VPTB:
35–39, 40–44, 45–49 years
ORs 1.16 to 1.72 (1.06 to 2.36)*
*lowest and highest 95% CI
Paternal age 25–29 years,
maternal age 25–29 years
PTB, VPTB:
U-shaped risk with significantly higher risk for
low and high paternal age
High
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Basso and Wilcox
(2006), Denmark
Cohort study 2 499 633 live singletons VPTB:
Paternal age 30–34, 35–39,
40–44, 45–49 years: AORs 0.86
to 1.11 (0.47 to 1.55)*
Highest AOR among fathers ≥50
years 1.3 (0.6–2.8) among women
20–24 years
*lowest and highest 95% CI
Paternal age 25–29 years,
maternal age 25–29 years
No increase in VPTB by paternal age. Stratified
for maternal age (20–24, 25–29, 30–34 years),
adjusted for mother’s education and smoking
High
Chen et al. (2008),
USA
Cohort study 2 614 966 singletons Paternal age <20 years:
PTB, VPTB, LBW, SGA, NND,
low Apgar score:
AORs 1.13 to 1.22 (1.01 to 1.49)*
*lowest and highest 95% CI
Paternal age 20–29 years PTB, VPTB, LBW, SGA, NND, low Apgar
score:
Significantly higher risk for young age. For high
age no significantly increased age up to >50
years.
Adjusted for paternal race, maternal age,
educational level, smoking, alcohol, prenatal care
and infant gender
High
Iwayama et al.
(2011), Japan
Cohort study 55 005/73 993 infants
selected at 1 month and
17 263/73 993 at 12
month healthy baby
check-up, 3588
underwent both 1 and 12
months check-up
BW increased with paternal age
for non-firstborn infants (P =
0.0004) and LBW decreased with
paternal age for non-firstborn
infants (P = 0.0022)
Paternal age was
categorized: <20, 20–29,
30–39, 40–49 and ≥50
years. The younger
category group was the
reference group.
Birth weight:
Also included in childhood morbidity.
Adjusted for maternal age
Low
Nybo Andersen
et al. (2004),
Denmark
Cohort study 23 821 pregnancies Late foetal death (≥20 weeks):
Paternal age ≥ 50 years:
AHR 3.9 (1.12–13.8)
(3 events), otherwise NS
Paternal age 25–29 years Stillbirth:
Significantly higher high for older fathers.
Adjustment for maternal age, reproductive
history and maternal life style during pregnancy.
Not included in meta-analysis, due to overlap
with Urhoj et al. (2017a)
Medium
Olshan et al. (1995),
USA
Cohort study 254 892 singletons No increase in PTB, LBW and
SGA by paternal age
Paternal age 25–29 years PTB, LBW, SGA:
Adjusted for maternal age, race, gravidity,
smoking, marital status, education and infant
gender
Medium
Reichman and
Teitler (2006), USA
Cohort study 4621 singletons Paternal age >34 years:
LBW: AOR 1.7 (1.3–2.2)
Paternal age 20–34 years LBW:
Significantly increased for older fathers.
Adjusted for maternal age, gender, mother’s
birth place, parity, marital status and health
insurance status.
Medium/low
Selvin and Garfinkel
(1972), USA
Cohort study 1 515 433 singletons U-shaped relation with slightly
higher rates of LBW at young and
older paternal ages
No LBW:
Adjusted for maternal age
Low
Stern et al. (2014),
USA
Cohort study 9092 ART singletons
6238 subfertile singletons
318 816 fertile singletons
Fertile group:
Paternal age 35–40, 41–45, ≥46
years:
No association with paternal age
and PTB, LBW or SGA
Paternal age ≤34 years,
maternal age ≤34 years
PTB, LBW, SGA:
Adjusted for parental race and ethnicity,
parental education, diabetes, chronic
hypertension. Stratified for maternal age, ≤34
and 35–40 years.
Medium
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Table I Continued
Author, year,
country
Study design Number of
pregnancies, births or
children
Result Outcomes
Comments
Adjustments
Study quality
Outcomes (risk estimates) Reference group/
controls
Tough et al. (2003),
Canada
Cohort study 283 956 births Paternal age 20–24, 25–29,
30–34. 35–39, 40–44 years:
Significantly decreased risk of
LBW: AORs 0.76 to 0.84 (0.67 to
0.95)*
PTB: AORs 0.75 to 0.87 (0.66 to
0.97)*
* lowest and highest 95% CI
Paternal age ≤19 years LBW, PTB: Reference group inadequate.
Adjusted for maternal age.
Medium
Urhoj et al. (2017a),
Denmark
Cohort study 944 031 pregnancies with
gestational age ≥22
weeks, 4946 stillbirths
Paternal age 35–39, 40–44 and
≥50 years:
Stillbirth: AHRs 1.16 to 1.58 (1.07
to 2.11)*
* lowest and highest 95% CI
Paternal age 30–34 years Stillbirth:
Paternal age associated with the risk of stillbirth
in a J-shaped manner with the highest adjusted
HRs among fathers >50 years.
Adjusted for maternal age in 1 year categories,
year of birth: 1994–1999, 2000–2005,
2006–2010, parental education, in sensitivity
analysis also for ethnicity, maternal reproductive
history
High
Zakar et al. (2015),
Pakistan
Cohort study 5724 births Paternal age (15–24 years or ≥40
years) was not associated with
‘small size at birth’ (SSB) or NND
Paternal age 25–39 years LBW:
LBW was a composite of several variables and
defined as ‘small size at birth (SSB)’ (no standard
definitions). Controlled for maternal and
pregnancy related factors.
Low
Zhu et al. (2005a),
Denmark
Cohort study 70 347 singletons PTB:
35–39 years: AOR 1.1 (1.0–1.3)
40–44 years: AOR 1.2 (1.0–1.4)
VPTB:
35–39 years: AOR 1.4 (1.0–2.0)
40–44 years: AOR 1.7 (1.1–2.6)
Paternal age 20–24 years PTB, VPTB:
Risk of PTB, mainly VPTB increased with
paternal age
Adjusted maternal age, parity, paternal
education and income, calendar year and infant
gender
High
AOR, adjusted odds ratio; AHR, adjusted hazard ratio; LBW, low birth weight (<2500 g); NND, neonatal death; OR, odds ratio; PTB, preterm birth (<37 weeks); SGA, small for gestational age; SSB, small size at birth; VPTB, very PTB
(<32 weeks)
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stillbirth when fathers were 40 or more, compared with fathers
below 40 years of age. Alio et al. (2012) also found a significantly
increased risk of stillbirth (more than 700,000 US births) for fathers
more than 40 years old, when compared to fathers between 25 and
29 years after adjustment for multiple confounders. Two Danish
studies with partial overlap (Nybo Andersen et al., 2004 ~24 000
births and Urhoj et al., 2017a almost 1 million births) found signifi-
cantly increased risks for the offspring of fathers of 50 years or more
(Nybo Andersen HR 3.9, reference group 25–29 years and Urhoj HR
1.58, reference group 30–34 years) (Nybo Andersen et al., 2004;
NOTE: Weights are from random effects analysis
.
.
.
.
Overall  (I-squared = 78.4%, p = 0.000)
Chen et al. (2008)
Subtotal  (I-squared = 77.0%, p = 0.000)
Olshan et al. (1995)
Olshan et al. (1995)
Abel et al. (2002)
Stern et al. (2014)
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Figure 2 Forest plot describing the association between paternal age and risk for PTB. AOR, adjusted odds ratios.
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Urhoj et al., 2017a). Our meta-analysis, including three studies, showed
a higher risk of stillbirth for the children of older than younger fathers
(reference groups varied between 20 and 40 years) with a pooled esti-
mate of 1.19 (95% CI 1.10–1.30) (Fig. 4). Two cohort studies reported
on NND; one of high quality (Chen et al., 2008) and one of low quality
(Zakar et al., 2015). No increased risk of NND was found.
Conclusion: The risk of stillbirth may be slightly increased for old-
er fathers. Low certainty of evidence (GRADE⊕⊕○○). It is uncer-
tain whether there is an association between paternal age and NND.
Very low certainty of evidence (GRADE⊕○○○).
Birth defects and chromosomal anomalies
Children with birth defects. Five studies assessed children with birth
defects, three of high quality, one of medium and one of low quality
(Supplementary Table SI, Table II). In a meta-analysis, four of these
studies could be included. A small, but significantly higher risk of birth
defects was associated with increasing paternal age (pooled estimate
1.05, 95% CI 1.02–1.07) (Fig. 5). The increase was found already at
age 35 years and above.
Conclusion: Higher paternal age is probably associated with a
small increase in birth defects. Moderate certainty of evidence
(GRADE⊕⊕⊕○).
Congenital heart defects. Seven studies investigated the association
between paternal age and CHDs (Supplementary Table SI, Table II).
Five of these studies were high quality, one medium and one of low
quality. All studies could be included in the meta-analysis. No signifi-
cant association was identified between paternal age and CHD
(pooled estimate 1.03, 95% CI 0.99–1.06) (Fig. 6).
NOTE: Weights are from random effects analysis
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Figure 3 Forest plot describing the association between paternal age and risk for LBW in offspring.
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Conclusion: Higher paternal age is probably associated with little
or no difference in the risk of CHD. Moderate certainty of evidence
(GRADE⊕⊕⊕○).
Orofacial clefts. We identified 13 studies, eight of high quality, three of
medium quality and two of low quality, for an assessment of orofacial
clefts (Supplementary Table SI, Table II). In addition, a systematic
review/meta-analysis has analysed the influence of parental age on oral
clefts (Herkrath et al., 2012). For paternal age, only two studies could
be included in their meta-analysis. A paternal age of 40 years and above
was associated with an increased risk of cleft palate (OR 1.58, 95% CI
1.15–2.17). We performed a meta-analysis including five studies (Fig. 7).
No overall effect of increased paternal age on the incidence of orofacial
clefts was found (pooled estimate 0.99, 95% CI 0.95–1.04) while an age
of above 45 years was associated with a small but significant increase in
orofacial clefts (pooled estimate 1.14, 95% CI 1.02–1.29 (Fig. 7).
Conclusion: Paternal age above 45 years may be associated with
a small increase in orofacial clefts. Low certainty of evidence
(GRADE ⊕⊕○○).
Gastroschisis. Five studies assessed the risk of gastroschisis in associ-
ation with paternal age, four of high and one of medium quality
(Supplementary Table SI, Table II). All these five studies are included in
the meta-analysis (Fig. 8). Overall, higher paternal age was not asso-
ciated with the risk of gastroschisis (pooled estimate 0.88 95% CI
0.78–1.00) (Fig. 8). A significantly lower rate was observed in children
whose fathers’ paternal ages were between 35 and 40 years, compared
to a reference age of between 25 and 29 years (U-shaped association).
Conclusion: Children of fathers aged 35 to 40 years probably
have a lower risk of gastroschisis than children of younger fathers.
Moderate certainty of evidence (GRADE⊕⊕⊕○).
Spina bifida. Five studies assessed the risk of spina bifida in associ-
ation with paternal age, three of high and two of medium quality
(Supplementary Table SI, Table II). All these five studies could be
included in a meta-analysis. No overall higher risk of spina bifida was
associated with increasing age (pooled estimate 0.97, 95% CI
0.90–1.04) (Fig. 9).
Conclusion: Higher paternal age is probably associated with little
or no difference in the risk of spina bifida. Moderate certainty of evi-
dence (GRADE⊕⊕⊕○).
Chromosomal anomalies. Twenty-three studies of chromosomal
anomalies were identified, most of them assessing trisomy 21
NOTE: Weights are from random effects analysis
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Figure 4 Forest plot describing the association between paternal age and risk for stillbirth in offspring.
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Table II Studies on the association of paternal age with birth defects and chromosomal anomalies in offspring.
Author, year,
country
Study design Number of deliveries
or children
Result Outcomes Study quality
Comments
AdjustmentsOutcomes (risk estimates) Reference group/
controls
Systematic review
Herkrath et al.
(2012), Brazil
Systematic review and
meta-analysis
80 articles included in SR,
13 articles in meta-
analysis, 2 articles about
increased paternal age
Paternal age >40 years:
Cleft palate: OR 1.58 (1.15–2.17)
Paternal age 20–39 years Non-syndromic oral cleft lip with or without
cleft palate and cleft palate. Meta-analysis
included Harville et al. (2007) and Poletta
et al. (2007)
Do not specify if adjusted for maternal age
Medium
Original articles n = 47
Archer et al. (2007),
USA
Cohort study Texas Birth Defect
Registry. 1996–2002,
denominator all live births
but number of total births
NA
Gastroschisis, n = 550
Trisomy 13, n = 143
Anencephaly, n = 248
Encephalocele, n = 118
Trisomy 21, n = 1870
Cleft palate, n = 2577
Spina bifida, n = 564
Paternal age:
Gastroschisis:
20–24 years: APR 1.47 (1.12–1.94)
Trisomy 21:
20–24 years: APR 1.28 (1.08–1.51
>40 years: APR 1.05 (0.88–1.24)
Trisomy 13:
>40 years: APR 0.40 (0.16–0.96)
Cleft palate:
20–24 years: APR 1.18 (1.00–1.38)
>40 years: APR 0.91 (0.71–1.16)
Pyloric stenosis
>40 years:APR 0.84 (0.72–0.98)
Anencephaly, spina bifida,
encephalocele, ASD, VSD (NS)
Paternal age 25–29 years Selected birth defects.
Adjusted for maternal age, race/ethnicity,
parity
Totally 18.6% had missing paternal age
High
Berg et al. (2015),
Norway
Cohort study 2890 cleft lip (with or
without cleft palate) from
2 449 218 births
Paternal age:
30–34 years: ARR 0.89 (0.80–0.98)
35–39 years: ARR 0.91 (0.79–1.04)
40–44: ARR 0.97 (0.80–1.17)
45–49: ARR 1.21 (0.92–1.58)
>50: ARR 1.18 (0.78–1.79)
Paternal age 25–29 years
Baseline risk 1.15/1000
Cleft lip with or without cleft palate
Adjusted for maternal age
Interaction analysis showed that the risk
was increased only if the age was increased
in both parents
High
Bille et al. (2005),
Denmark
Cohort study 1 489 014 births with 1920
non-syndromic (fewer than
3 associated minor
anomalies) cleft lip with or
without cleft palate + 956
cleft palate only
Paternal age 20–50 years: per 10 years
increase in age AOR 1.12 (1.02–1.22)
for cleft lip with or without cleft palate
and AOR 1.24 (1.10–1.40) for cleft
palate only
No reference group Cleft lip with or without cleft palate
Adjustment for maternal age
Both maternal and paternal ages were
associated with the risk of cleft lip with or
without cleft palate. For cleft palate alone,
only paternal age was a risk factor
High
Bunin et al. (1997),
USA
Case control 89 cases Paternal age (mean ± SE)
29.9 ± 0.6
Age difference 1.5 years, P = 0.07
versus controls
30–34 years OR 1.8 (P = 0.05)
35–39 years: OR 0.9 (P = 0.82)
≥40 years: OR 2.9 (P = 0.07)
178 controls (mean ± SE)
28.3 ± 0.5
Reference group: Paternal
age <30 years
Sporadic neurofibromatosis. Two kind of
analyses, one with a control group and
another with a reference group
Adjustment for maternal age or socio-
economic status did not change the results
Low
Cross and Hook
(1987), USA
Cohort study 35 680 foetuses with
prenatal cytogenetic
No statistically significant effect of any
paternal age for trisomy 21
None Trisomy 21
Adjustment for maternal age
High
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analysis (amniocentesis,
age indication)
de Michelena et al.
(1993), Peru
Case control 318 children and teen
agers with trisomy 21
Means of paternal age for all ages, and
for maternal age groups <21, 21–29.
30–34, 35–39 and >39 years were
similar (P ≥ 0.1)
1196 controls
(4 controls/ cases)
Trisomy 21
Controls were matched on date of birth,
sex and maternal age
Low
De Souza et al.
(2009), UK
Case control 471 cases No statistically significant association
between paternal age and trisomy 21,
AOR 1.13 (0.85–1.52) per 10 year
increase
456 controls (parents of
children with other
disabilities)
Trisomy 21
Controls were matched on maternal age
(within 3.5 years) and year of birth (within 3
years)
Low
De Souza and Morris
(2010), UK
Case control 374 cases with trisomy
13, 929 with trisomy 18,
295 with Klinefelter and
28 with XYY syndrome
Per 10 year increase in paternal age
(adjusted for the association of trisomy
21 with paternal age = AOR 1.11
[1.01–1.23]):
Relative (adjusted) to the population
Trisomy 13: AOR 1.10 (0.83–1.45)
Trisomy 18: AOR 1.15 (0.96–1.38)
Klinefelter: AOR 1.36 (1.02–1.79)
XYY: AOR 1.99 (0.75–5.26)
Population and 5627
controls with trisomy 21
Trisomy 13, trisomy 18, Klinefelter (XXY),
XYY syndrome
Controls were matched on maternal age
(within 6 months)
Low
Dzurova and Pikhart
(2005), USA and
Czech Republic
Cohort study Trisomy 21/all births:
593/516 745 (California)
and
251/475 834 (Czech
Republic)
AOR 0.54–1.02 and NS in California,
and AOR 1.49–2.03 and NS in Czech
Republic
Paternal age <19 years Trisomy 21
Adjusted for maternal age, education of
mother and sex of infants, 2 years
categories
Paternal age missing in 17% in Czech
Republic
Medium
Erickson and Cohen
(1974), USA
Case control 44/56 cases analysed Mean paternal age in cases with Apert
syndrome: 34.8 years
‘Increased paternal age’
Mean paternal age
‘population’ 32.4 years
Apert syndrome, no statistics given Low
Erickson (1978),
USA
Case control 4000 white infants with
trisomy 21
No independent effect of paternal age
(maternal age and birth order
constant), rates at paternal age >45
years were constant
‘Some’ 86 000 normal
white infants
Trisomy 21 Medium
Erickson (1979),
USA
Cohort study 2 data sources, Atlanta
data: 226 cases and
National Centre for
Health Statistics (NCHS)
data: 1858 cases
Atlanta and NCHS data: no
independent paternal age effect using
cut off for paternal age ≥40, 45 and 50
years
Atlanta data 161 452
white and 71 193 black
controls, NHCS 4597 305
controls
Trisomy 21 Medium
Erickson and
Bjerkedal (1981),
Norway
Cohort study 693 cases Small age effect in paternal age ≥50
years
685 000 controls Trisomy 21
Stratified for maternal age
No statistics given
Medium
Finley et al. (1990),
USA
Case control 14 cases of sporadic
blepharophimosis, ptosis,
epicanthus inversus,
telecanthus complex
(BPEI), control data from
national means from US
statistics
Mean maternal and paternal age higher
in cases
US national means
1966–1975
Blepharophimosis, ptosis, epicanthus
inversus, telecanthus complex (BPEI),
(autosomal dominant disorder)
No statistics given
Low
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Table II Continued
Author, year,
country
Study design Number of deliveries
or children
Result Outcomes Study quality
Comments
AdjustmentsOutcomes (risk estimates) Reference group/
controls
Fisch et al. (2003),
USA
Case series 3419/4387 cases Effect of paternal age only in mothers
>35 years (P = 0.0023) and most
pronounced in mothers >40 years
(P = 0.0004)
None Trisomy 21 Low
Green et al. (2010),
USA
Case control Cases with birth defects
(if n ≥ 100), between 102
to 6629 cases
Paternal age 40 years
All orofacial clefts: AOR 1.07
(0.94–1.23)
Septal defects: AOR 0.98 (0.87–1.10)
Spina bifida: AOR 1.03 (0.82–1.28)
Omphalocele: AOR 0.92 (0.64–1.33)
Gastroschisis: AOR 0.80 (0.54–1.21)
Control group of 5839
normal live born infants.
Paternal age 30 years.
Maternal age 28 years
Selected birth defects
Adjusted for paternal race and ethnicity,
paternal education, maternal alcohol,
maternal smoking, parity, earlier
miscarriage, plurality, paternal drug used
during pregnancy, use of ART, maternal
BMI, folic acid use
Medium
Grewal et al. (2012),
USA
Case control 46 114 cases with birth
defects
Paternal age:
Nervous system anomalies:
38 years: AOR 1.05 (1.00–1.11)
42 years: AOR 1.10 (1.02–1.18)
Limb anomalies:
38 years: AOR 1.06 (1.02–1.11)
42 years: AOR 1.11 (1.05–1.18)
Integument anomalies:
38 years: AOR 1.05 (1.00–1.09)
42 years: AOR 1.10 (1.03–1.16)
For fathers 29 years versus <29 years:
Amniotic band syndrome: AOR 0.87
(0.78–0.97)
Pyloric stenosis: AOR 0.93 (0.90–0.96)
Anomalies of the great veins: AOR
0.93 (0.87–1.00)
Paternal age
29 year
A random sample of
36 838 non-malformed
births
Selected birth defects
Adjusted for maternal age
Medium
Harville et al. (2007),
Norway
Cohort study 1431 cases Paternal age:
Cleft palate alone:
30–34 years: AOR 1.00 (0.76–1.31)
35–39 years: AOR 0.94 (0.68–1.30)
≥40 years: AOR 1.10 80.76–1.60)
Paternal age 20–24 years
1.8 million controls
Cleft palate alone
Stratified for maternal age,
20–29 years
High
Hook et al. (1981),
USA
Cohort study 551 cases 1952–1963 and
492 cases 1964–1976
For 1952–1963 there was no
significant paternal age effect (36.87
versus 36.82 years)
For 1964–1976, paternal age was
about half a year greater in cases than
in controls (34.55 versus 34.09 years,
P < 0.05)
418 017 births
1952–1963
418 848 births
1964–1976
Trisomy 21
Controlled for maternal age
Medium
Hook and Cross
(1982), USA
Case control 98 cases of prenatally
detected trisomy 21
Mean difference in paternal age 0.27
(−1.59 to +1.06)
10 239 foetuses with
normal karyotype
Trisomy 21
Controlled for maternal age
Medium
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Hook and Regal
(1984), USA
Case control 2354 cases with trisomy
21, 116 cases with
trisomy 13 (including
cases prenatally
diagnosed)
No effect of paternal age Controls were from all
live births the same year
in New York State
Trisomy 21 and trisomy 13 associated with
Robertsonian translocations
Controlled for maternal age and year of
birth
Low
Kazaura and Lie
(2002), Norway
Cohort study 1 738 852 infants
1788 trisomy 21
No increase by paternal age
AOR 1.11 (0.99–1.22) per 10 year
increase in paternal age
None Trisomy 21
Adjusted for maternal age as a continuous
variable, birth calendar year and place of
birth
High
Kazaura et al.
(2004a), Norway
Cohort study 291 cases with
gastroschisis
Higher risk at young paternal age
AOR 1.6 (1.0–2.4) per 10 year
decrease in paternal age after
adjustment for maternal age, but was
not significant after adjustment for
paternal year of birth, AOR per year
of father’s age:
1.04 (0.99–1.08)
>1.7 million controls Gastroschisis
Adjusted for maternal age, paternal year of
birth
High
Kazaura et al.
(2004b), Norway
Cohort study 1 869 388 births, 42 813
infants with birth defects
Paternal age 45–49 years:
CNS defects (not neural tube defects,
anencephaly, spina bifida or
hydrocephaly)
AOR 2.5 (1.2–5.5)
Paternal age 20–24 years:
Anencephaly AOR 1.4 (1.1–1.8)
Neural tube defects. AOR 1.3
(1.1–1.5)
Cleft lip: AOR between 0.9–1.2 (NS)
Any birth defects: AOR 1.0–1.1
(borderline significant)
Paternal age 25–29 years Any and selected birth defects
Adjusted for maternal age, parity, maternity
institution and year of birth
High
Lian et al. (1986),
USA
Cohort study 7490 infants with a major
or serious birth defect
Paternal age ≥35 years versus <35
years:
ASD: AOR 1.95 (significant) Paternal
age ≥40 years versus <40 years:
Any birth defect: AOR 1.20 (significant)
VSD: AOR 1.69 (significant)
Chondrodystrophy: AOR 13.32
(significant)
Situs inversus: AOR 19.27 (significant)
Paternal age ≥45 versus <45 years
Cleft palate/lip: AOR 2.86 (significant)
Trisomy 21: NS any age
333 624 live born control
infants without defects
Any and selected birth defects (86 groups
of defects)
Adjusted for maternal age and race
AOR given but no 95% CI.
Medium
Lorda-Sanchez et al.
(1998), Spain
Case control 14 cases Associated with increase in:
Paternal age (34.5 ± 6.0 versus 29.6 ±
6.0), OR 1.11 (1.02–1.21) but NS after
adjustment for maternal age and no of
pregnancies
162 controls Klippel–Trenaunay–Weber syndrome Low
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Table II Continued
Author, year,
country
Study design Number of deliveries
or children
Result Outcomes Study quality
Comments
AdjustmentsOutcomes (risk estimates) Reference group/
controls
Materna-Kiryluk
et al. (2009), Polen
Cohort study 8683 infants 0–2 years
with birth defects
AOR (per five years increase in
paternal age)
Heart defects: AOR 1.05 (1.00–1.09)
Cleft lip with or without cleft palate:
AOR 1.11 (1.02–1.20)
Hypospadia: AOR 1.11 (1.03–1.19)
Gastroschisis: AOR 0.69 (0.54–0.90)
902 452 population Selected birth defects
Adjusted for maternal age
High
McIntosh et al.
(1995), USA
Case control 9431 cases with 22
different birth defects
(Trisomy 21, n = 997,
cleft palate, n = 1489)
Neural tube defects
Paternal age 40–44, >50 years
AORs 1.6 and 2.3 (borderline
significant)
Reduction of upper limbs 35–39,
40–44 years
AORs: 2.1 and 2.4 (significant)
Trisomy 21:
40–44, 45–49, ≥50 years
AORs 1.5 to 2.0 (significant)
Cleft palate: AORs 0.8–1.5 (NS)
18 862 controls
Paternal age 25–29 years
Selected birth defects
Adjusted for maternal age
Medium
Olshan et al. (1994),
USA
Case control 4110 cases with CHD General increase by paternal age with
trend analysis, NS per age group
8220 controls
Paternal age 25–29 years
CHDs
Adjusted for maternal age, no of stillbirths,
race
Low
Orioli et al. (1995),
Italy
Case control 78 cases with
achondroplasia (AC)
64 cases with
thanatophoric dysplasia
(TD)
106 cases with
osteogenesis imperfecta
(OI)
Paternal age >35 years
AC: AOR 3.71 (1.7–8.08) (also
mother’s age < 30 sign)
TD: AOR 3.37 (1.43–8.0)
OI: AOR 1.44 (0.78–2.64)
2 controls per cases
Paternal age <30 years
Maternal age >30 years
Achondroplasia (AC), thanatophoric
dysplasia (TD), osteogenesis imperfecta
(OI),
Stratified for maternal age > and <30 years
Low
Polednak (1976),
USA
Cohort study 897 orofacial clefts Total malformation rate: NS
Syndactyly: P < 0.05
Oral cleft rate 1.13/1000, P < 0.01
776 642 population
Maternal age 25–29 years
Any and selected birth defects. Stratified for
maternal age
Low
Poletta et al. (2007),
South America
Case control 5128 cleft lip/palate,
1745 cleft palate
Among 3/11 strata (representing 50%
of the cases) significant higher risk with
paternal age, ORs between 1.42–3.56
3712 controls Orofacial clefts, probably not adjusted for
maternal age
Medium/low
Riccardi et al.
(1984), USA
Case series 187 cases Paternal age >35 years:
2-fold increase
Year matched population
controls (from general
population).
Paternal age <35
Neurofibromatosis
Controlled for maternal age
Low
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Roecker and
Huether (1983),
USA
Cohort study 1244 cases No paternal age effect 1 672 210 controls Trisomy 21
Stratified for maternal age
Low
Roth et al. (1983a),
France
Case control 118 cases No effect of paternal age
Mean difference in paternal age: 0.46
(−0.84 to +1.76)
6656 prenatal diagnoses
(amniocentesis)
Trisomy 21
Controlled for maternal age
Low
Roth et al. (1983b),
France
Case series
Case control
2 studies:
1:611 cases with trisomy
21
2:242 cases with trisomy
21
No effect of paternal age
Mean difference in paternal age: 0.46
(−0.34 to +1.26)
2 controls per cases in
study 2
Trisomy 21
Controlled for maternal age and time and
place of birth
Low
Stene et al. (1977),
Denmark
Case control 224 cases Increased risk of trisomy 21 with
paternal age >55 years
5619 controls Trisomy 21
Controlled for maternal age
No statistics
Low
Stene et al. (1981),
Denmark
Case control 117 cases Increased risk of trisomy 21 by
paternal age >41 years
5014 prenatal diagnoses Trisomy 21
Controlled for maternal age
No statistics
Low
Su et al. (2015),
China
Cohort study
(Denmark)
15 216 cases with CHDs No overall effect of paternal age
for CHD
PDA (>45 years): AHR 1.69
(1.17–2.43)
1 893 899 population
Paternal age 25–29 years
CHDs
Controlled for maternal age, family history
of CHD, maternal infection, gender, parity,
parental age difference
High
Takano et al. (1992),
Japan
Cohort study 26 cases No significant effect of paternal age
(P = 0.08)
Population controls Neurofibromatosis Low
Tay et al. (1982),
Singapore
Case control 100 cases No effect of paternal age 100 controls Congenital heart disease Low
Tellier et al. (1996),
France
Cohort study 41 cases with CHARGE Significant higher mean paternal age
versus control population
Mean paternal age: 33.7+-8 versus
30.8+-5 years (P < 0.05)
Control population not
described
CHARGE malformations (coloboma, heart
malformation, choanal atresia, retarded
growth, genital hypoplasia, ear anomalies
and deafness etc)
No difference in maternal age
Low
Urhoj et al. (2015),
Denmark
Cohort study 10 817 cases with
musculoskeletal
congenital abnormalities
AOR 1.06 (1.01–1.11) by 10 years
increase for any musculoskeletal
congenital abnormalities
26% increase (2–56%) for paternal age
>50 versus 30–34 years
1 605 885 population Musculoskeletal congenital abnormalities
Adjusted for maternal age, year of birth,
ethnicity and education
High
Vashist et al. (2011),
India
Case series 200 cases with trisomy 21 Association with paternal age
(correlation coeff (r) = 0.04, maternal
age constant)
Mean paternal age 31.5
years
Trisomy 21 Low
Wolf (1963), USA Case control 411 cases with cleft lip
and palate
A significant paternal age effect (P <
0.05)
411 controls Cleft lip and palate
Controlled for maternal age
Low
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Table II Continued
Author, year,
country
Study design Number of deliveries
or children
Result Outcomes Study quality
Comments
AdjustmentsOutcomes (risk estimates) Reference group/
controls
Yang et al. (2007),
Canada
Cohort study 77 514 cases with birth
defects
(Trisomy, n = 13 078,
cleft palate, n = 6049)
Paternal age 35–39, 40–44, 45–49,
≥50 years
Any birth defects:
AORs: 1.04–1.15
(significant), test for trend P = 0.015
Trisomy 21: AORs 1.19–1.45
(significant), test for trend P < 0.01
Cleft palate: AOR 0.89–1.23 (NS for
any age group)
5 213 248 population
Paternal age 25–29 years
Any and selected birth defects
Advanced paternal age was associated with:
Any birth defects, heart defects, tracheo-
oesophageal fistula, oesophageal atresia,
musculoskeletal/ integumental anomalies,
trisomy 21 and other chromosomal
anomalies
Paternal age <25 years were associated
with: Spina bifida/ meningocele,
microcephalus, omphalocele/gastroschisis
Adjusted for maternal age, race, education,
marital status, parity, prenatal care,
smoking, alcohol consumption in woman
High
Zhan et al. (1991),
China
Case control 497 cases with CHDs Paternal age <25 years
AOR:2.63 (2.12–3.27)
6222 controls
Paternal age ≥25 years
Congenital heart disease
Controlled for maternal age and birth order
Low
Zhu et al. (2005b),
USA and Denmark
Cohort study 3910 cases with birth
defects
(Trisomy 21, n = 46
Cleft palate/lip, n = 162)
No overall effect for any birth defect
Paternal age >50 years:
Trisomy 21
AHR: 4.50 (1.0–20.39)
Paternal age 35–39 years:
Cleft palate: AHR 1.48 (1.02–2.15)
Multiple syndromes, extremities,
increased by age, test for trend P <
0.001–0.05
71 937 population
Paternal age 20–29 years
Any and selected birth defectsAdjusted for
maternal age, parity, maternal and paternal
income and education, sex of child and year
of birth
High
AC, achondroplasia; APR, adjusted prevalence ratio; CHD, congenital heart defects; OI, osteogenesis imperfecta; PDA, persistent ductus arteriosus; TD, thanatophoric dysplasia.
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(Supplementary Table SI, Table II). Five of these studies were high-quality
cohort studies, nine were medium and nine were low quality, mostly
case control studies (Supplementary Table SV). Altogether these studies
included more than 37 000 (37 513) children with trisomy 21. Six of the
studies could be included in a meta-analysis (Fig. 10). The meta-analysis
identified a small but significantly increased risk of trisomy 21 associated
with paternal age (pooled estimate 1.13, 95% CI 1.05–1.23). The rate
was significantly increased at ages 40 years and above (Fig. 10). For other
aneuploidies (trisomy 13 and 18), one high quality study could not identify
any increase by paternal age.
Conclusion: Higher paternal age is probably associated with a
small increase in the incidence of trisomy 21. Moderate certainty of
evidence (GRADE⊕⊕⊕○).
Paternal age at childbirth and long-term
outcomes for offspring
Morbidity and mortality
Twenty-two studies assessed the effect of paternal age on childhood
morbidity including childhood cancer (13 studies), diabetes and obesity
(three studies), developmental disturbances (one study) and mortality
(five studies). In addition, one meta-analysis concentrated on the risk of
leukaemia (Sergentanis et al., 2015).
Childhood cancer. We identified 13 studies, four of high quality, six of
medium quality and three of low quality. They examined childhood
cancer in general as well as haematological cancer and leukaemia, ret-
inoblastoma, non-Hodgkin lymphoma, Wilm’s tumour and brain
tumours in particular (Supplementary Table SI, Table III).
Five studies assessed the effect of paternal age on the incidence of
retinoblastoma. Only one study adjusted for maternal age (Yip et al.,
2006), and did not report an association between paternal age and
retinoblastoma.
In addition, in one systematic review/meta-analysis, the effect of
paternal age on the risk of childhood leukaemia was assessed. This
showed that higher paternal age was associated with an increased
risk of childhood acute lymphoblastic leukaemia (ALL) (RR 1.05, 95%
CI 1.01–1.10, per year increments: RR 1.04, 95% CI 1.00–1.08)
(Sergentanis et al., 2015).
NOTE: Weights are from random effects analysis
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Figure 5 Forest plot describing the association between paternal age and risk for any birth defects in offspring.
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NOTE: Weights are from random effects analysis
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Figure 6 Forest plot describing the association between paternal age and risk for CHDs in offspring,
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Two studies adjusted for maternal age and could be included
in a meta-analysis (Fig. 11). No overall higher risk of ALL was
associated with increasing age (pooled estimate 1.08, 95% CI
0.96–1.21).
Conclusion: Higher paternal age is probably associated with little
or no difference in the risk of ALL. Moderate certainty of evidence
(GRADE⊕⊕⊕○). Higher paternal age may be associated with little
or no difference in the risk of other childhood cancers. Low certainty
of evidence (GRADE⊕⊕○○).
Diabetes mellitus type 1 and obesity. Two cohort studies concentrated
on paternal age and diabetes mellitus (DM) type 1, and one study on
NOTE: Weights are from random effects analysis
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Figure 7 Forest plot describing the association between paternal age and risk for orofacial clefts in offspring.
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overweight and obesity. Two of these studies were of high quality
and one of medium quality (Supplementary Table SI, Table III). In
both studies concerning DM, adjustments were made for maternal
age. One study (Cardwell et al., 2005) reported an association with
paternal age, and the other (Stene et al., 2001) found that paternal
age was not significantly associated with DM type 1. One study asso-
ciated an increased risk of obesity with paternal age > 50 years
(Eriksen et al., 2013).
Conclusion: It is uncertain whether paternal age is associated
with an increased risk of DM type 1 and obesity in offspring. Very
low certainty of evidence (GRADE⊕○○○).
Mortality. Infant mortality during the first year of life and the possible
effects of paternal age were studied by Wunsch and Gourbin (2002),
while Urhoj et al. (2014) looked into mortality before the age of 5
years. Three studies concentrated on mortality up to 18, 39, and 40
years, respectively (Zhu et al., 2008; Miller et al., 2010; Mok et al.,
2017) (Supplementary Table SI, Table III). In all studies, except
Wunsch and Gourbin (2002), adjustments were made for maternal
age. These four studies also reported an association of mortality with
higher paternal age. It was not possible to do a meta-analysis because
of different length of follow-up in the studies.
Conclusion: Higher paternal age may be associated with a small
increase in risk of mortality. Low certainty of evidence (GRADE
⊕⊕○○).
Psychiatric diseases/disorders in offspring of older fathers
Autism and ASDs. Two meta-analyses (Hultman et al., 2011; Wu
et al., 2017) and 28 original studies assessed the effect of paternal
age on autism and ASD (Supplementary Table SI, Table IV). The ori-
ginal articles included 15 cohort studies and 13 case control studies.
Five studies were of high quality, 16 of medium quality and seven of
low quality. The systematic review/meta-analysis by Hultman et al.
(2011) included 12 studies from seven different countries. The
pooled estimates for autism and ASD were for offspring of fathers
between 40 and 49 years old 1.78 (95% CI 1.52–2.07), and for off-
spring of fathers ≥50 years old 2.46 (95% CI 2.20–2.76). In the
meta-analysis by Wu et al. (2017) including 27 studies, a significant associ-
ation between paternal age and the risk of autism in offspring was
found (AOR 1.55, 95% CI 1.39–1.73). We included 16 studies in our
NOTE: Weights are from random effects analysis
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Figure 8 Forest plot describing the association between paternal age and risk for gastroschisis in offspring.
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meta-analysis (Fig. 12). All of these studies adjusted for maternal age.
It was observed that there was a higher risk of autism/ASD with
increasing paternal age (pooled estimate 1.25, 95% CI 1.20–1.30).
Conclusion: Higher paternal age is probably associated with
an increase in autism/ASD. Moderate certainty of evidence
(GRADE⊕⊕⊕○)
Schizophrenia. Three meta-analyses (Wohl and Gorwood, 2007;
Torrey et al., 2009; Miller et al., 2010) and 19 original studies assessed
the effect of paternal age on the risk of schizophrenia in offspring. The
original articles included 10 cohort studies and 9 case control studies.
No studies of high quality, 9 of medium quality and 10 of low quality
were included (Supplementary Table SI, Table V). The meta-analysis by
Miller et al. (2010) included six cohort and six case control studies. In
both study designs, a significant increase in the risk of schizophrenia in
the offspring of older fathers was found. The relative risk in the oldest
fathers (≥50 years) was 1.66 (95% CI 1.46–1.89). The meta-analysis by
Torrey et al. (2009) included ten studies and found an increased risk of
schizophrenia in the offspring of the older fathers. The pooled estimate
of risk of schizophrenia in offspring of fathers ≥55 years of age was 2.21
(95% CI 1.46–3.37) and for fathers ≥45 years the pooled estimate was
1.38 (95% CI 0.95–2.01). Wohl and Gorwood (2007) reported an
association with paternal age, with higher levels of schizophrenia in the
offspring of fathers younger than 20 and older than 35 years.
Fourteen of the original articles were included in a meta-analysis
(Fig. 13). All of these studies adjusted for maternal age. Paternal age
was categorized as <35, 35–39, 40–45, >45 and >50 years. A higher
risk of schizophrenia was associated with increasing paternal age
(pooled estimate 1.31, 95% CI 1.23–1.38).
Conclusion: Higher paternal age is probably associated with an
increased risk of schizophrenia in offspring. Moderate certainty of evi-
dence (GRADE⊕⊕⊕○).
NOTE: Weights are from random effects analysis
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Figure 9 Forest plot describing the association between paternal age and risk for spina bifida in offspring.
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Other psychiatric disorders. Fifteen studies concentrated on other psy-
chiatric conditions including attention deficit hyperactivity syndrome
(ADHD) (three studies), eating disorders (two studies), psychosis
(three studies), bipolar disorders (six studies), Tourette disorder (one
study) and neurocognitive development (one study) (Supplementary
Table SI, Table VI).
ADHD Two studies (D’Onofrio et al., 2014; Hvolgaard Mikkelsen
et al., 2016) were of high and one of medium quality (Chudal et al.,
NOTE: Weights are from random effects analysis
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Figure 10 Forest plot describing the association between paternal age and risk for trisomy 21 in offspring.
342 Oldereid et al.
Downloaded from https://academic.oup.com/humupd/article-abstract/24/3/320/4859613
by National Library of Health Sciences user
on 11 June 2018
...............................................................................
..........................................................................................................................................................................................................................................................
Table III Studies on the association of paternal age with childhood morbidity and mortality in offspring.
Author, year,
country
Study design Number of children Result Outcomes Quality
Outcomes (Risk estimates) Reference group/
control
Meta-analysis n = 1
Sergentanis et al.
(2015), Greece
Systematic review and
meta-analysis
Paternal age as categorical
variable:
34 case control studies and
4 cohort studies in
systematic review
As incremental variable:
9 case control studies and
3 cohort studies in
systematic review
Meta-analysis (incremental
analysis):
8 case control studies and
2 cohort studies
ALL:
A 5 year increase in paternal age: RR 1.04
(1.00–1.08)
‘Oldest versus middle’:
Increased risk in oldest fathers with RR
1.10 (1.02–1.19)
ARR 1.09 (0.90–1.25)
‘Youngest versus middle age’: increased risk
in youngest with
RR 1.09 (1.00–1.20)
ARR 1.10 (0.81–1.51)
AML:
No significant associations at incremental
analysis or ‘oldest versus middle’
Increased risk in offspring from ‘younger
fathers versus middle’ with pooled RR 1.28
(1.04–1.59)
ARR 0.63 (0.33–1.20)
Paternal age:
‘Older’:
>35 years or >40 years
‘Younger’:
<25 years
Many studies in forest plots did not adjust for
maternal age (RR), but sub-analyses regarding
degree of adjustments were included (ARR)
Medium
Original articles n = 22
Cardwell et al. (2005),
UK Northern Ireland
Cohort study 991 children with DM type
1
447 663 cohort
Paternal age:
>35 years ARR 1.52 (1.10–2.09)
Paternal age <25 years Children born 1971–1986 Diagnosed with DM type
1 at the age of 15 years
Adjusted for maternal age, birth order, year of birth
Medium
Crump et al. (2012),
Sweden
Cohort study 936 cases with non-
Hodgkin’s lymphoma
3 571 574 population
Adjusted risk estimates not mentioned in
text, no association, ptrend = 0.31
Probably paternal age
<20 years
Children born 1973–2008 followed through 2009
(ages 0–37 years).
Adjusted for perinatal and family variables including
maternal age
Medium
Crump et al. (2015),
Sweden
Cohort study 2809 cases with brain
Tumours
3 571 574 population
(25–29år)
Paternal age:
≥35 years AIRR 1.24 (0.82–1.85)
Paternal age 25–29
years
Children born 1973–2008 followed through 2010
(max age 38 years)
Adjusted for maternal age, birth year, sex, foetal
growth, parental country at birth, family history of
brain-tumour, maternal education
Medium
DerKinderen et al.
(1990), the NL
Cohort study 361 sporadic
retinoblastoma cases
Compared to general
population (number NA)
Paternal age:
20–24 years RR 0.4 (no confidence interval
available)
>50 years: RR 5 (no confidence interval
available)
Paternal age 25–34
years
Children born 1945–1970
No information about adjustments
Low
Dockerty et al.
(2001), UK
Case control 10 162 cases with
childhood cancer
10 162 controls
Paternal age:
Retinoblastoma:
40–45 years AOR 0.82 (95% CI 0.39–1.75)
≥45 years AOR 0.73 (95% CI 0.26–2.01)
ALL:
40–44 years AOR 1.45 (95% CI
1.10–1.92), ≥45 years AOR 1.54 (95% CI
1.06–2.23)
Paternal age 25–29
years
Children born 1968–1981
Not adjusted for maternal age
Medium
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Table III Continued
Author, year,
country
Study design Number of children Result Outcomes Quality
Outcomes (Risk estimates) Reference group/
control
Eriksen et al. (2013),
Norway
Cohort study 346 609 cohort
44 712 cases with
overweight
11 091 cases with obesity
Paternal age:
Overweight:
>50 years ARR 1.15 (0.98–1.35)
Obesity:
>50 years ARR? 1.55 (1.14–2.10)
Paternal age <20 years Male conscripts at 18–20 years, born 1967–1984
Overweight defined as BMI 25.0–29.9 kg/m2
Obesity defined as BMI > 30 kg/m2
Adjusted for birth order, birth years, birth season,
maternal age, parity of mother, maternal marital
status at birth, parental education level
High
Heck et al. (2012),
USA, California
Case control 609 cases with
retinoblastoma
209 051 controls
Paternal age:
30–34 years OR 1.44 (0.99–2.10)
≥35 years OR 1.75 (1.20–2.47)
Paternal age 20–29
years
Children diagnosed with retinoblastoma 1988–2007,
children up to 5 years
Confounding variables in multivariate models were
year of birth, paternal age, urban or rural county of
residence, maternal race and maternal place of birth.
No information about adjustment for maternal age
Medium
Iwayama et al. (2011),
Japan
Cohort study 72 268 cohort
16 762 cohort attending
check-up
Developmental delay AOR 2.25
(1.33–3.80) (36 cases)
No word uttering AOR 2.29 (1.52–3.44)
(60 cases)
Lack of eye contact AOR 5.16 (1.92–13.8)
(6 cases)
Unable to walk with support AOR 1.51
(1.21–1.91) (230 cases)
Paternal age was
categorized: <20,
20–29, 30–39, 40–49
and ≥50 years. The
younger category group
was the reference
group
Children attending child health check-up at age 12
months during 1987–2003 examining child growth
and developmental delay.
(Included in obstetric outcome, Table 1a)
Adjusted for maternal age
Low
Johnson et al. (2009),
USA
Case control 17 672 cases with
childhood cancer
57 966 controls
Paternal age:
Overall cancer AOR 1.01 (0.99–1.03)
Leukaemia AOR 1.03
(1.00–1.07)
OR related to a 5-year
increase in paternal age
Children 0–14 years diagnosed with cancer
1980–2004
Controls born 1970–2004
Adjusted for maternal age, sex, birth weight,
gestational age, birth order, plurality, maternal race,
birth year and state
High
Larfors et al. (2012),
Sweden
Case control 2660 cases (children) with
leukaemia (AML and ALL)
28 288 controls
Paternal age:
≥35 years childhood ALL:
AHR 1.08 (95% CI 0.95–1.23)
≥35 years childhood AML:
AHR 0.89 (95% CI 0.65–1.22)
Paternal age 20–34
years
Born 1932 or later, diagnosed with leukaemia
(children and adult leukaemia) during 1962–2008
Adjusted for sex, Down syndrome and
chromosomal aberrations, multiple birth, number of
siblings, maternal/paternal age
Medium
Matsunaga et al.
(1990), Japan
Case control 225 bilateral and 408
unilateral cases with
retinoblastoma
Respective 225 and 408
controls
No risk estimate (OR, RR or HR)
Only observed and expected numbers
No specific control
group
Born during 1965–1968 or 1975–1982
Adjusted by the birth of the children. No
adjustments for maternal age
Low
Maule et al. (2007),
Italy
Cohort study 229 cases with ALL
284 cases with embryonal
tumours
633 155 population
Paternal age:
≥40 years ALL: ARR 0.93 (0.52–1.67)
≥40 years embryonal tumours: 1.50
(0.90–2.48)
25–29 years Children aged 1–5 years 1980–1997
Adjusted for sex, year of birth, paternal/maternal
age
Medium
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Miller et al. (2010),
Finland
Cohort study 10 965 population
318 cases/deaths
Paternal age:
All causes mortality:
≥45 years AHR 3.45 (1.85–6.45)
Natural death:
≥45 years 2.93 (1.05–8.18)
Paternal age 25–29
years
Mortality in offspring born in 1966 and followed to
age 39
Adjusted for age of the other parent, subject age,
parent social class, maternal parity
Medium
Mok et al. (2017),
Denmark
Cohort study 1 793 681 population
Cases with premature
mortality, psychiatric
morbidity and criminality
Paternal age:
Natural death:
>45 years AIRR 1.28 (1.02–1.59)
Paternal age 25–29
years
Mortality in children born 1966–1998 and followed
to their 15th or 40th birthday or until 2011
Article also in Table 2d: other psychiatric disorders
Older paternal age not associated with premature
mortality after adjustments except for risk of natural
death linked with paternal age 45 years and over.
Adjusted for other parent’s age, offspring age and
sex
Medium
Stene et al. (2001),
Norway
Cohort study 1 382 602 population
1824 with DM type 1
Paternal age:
>40 year ARR 1.16 (0.92–1.46)
Paternal age < 25 years DM type 1 in children born 1974–1998, followed for
maximum 15 years until 1989–1998
Adjusted for age group year of birth, maternal age,
birth order
High
Teras et al. (2015),
USA
Cohort study 2532 cases with
haematological malignancies
138 003 population
Paternal age:
≥35år AHR 1.20 (1.01–1.42)
With no siblings:
≥35 years AHR 1.63 (1.19–2.23)
Paternal age < 25 years Haematological malignancies diagnosed 1992–2009
No clear linear trend in risk by paternal age
Adjusted for age of the other parent and sex
High
Urhoj et al. (2014),
Denmark
Cohort study 10 855 cases
1 575 521 population
Paternal age:
40–45 years AHR 1.10 (95% CI 1.00–1.21)
>45 years AHR 1.16 (95% CI 1.02–1.32)]
Reference group:
Paternal age 30–34
years
Mortality before the age of 5 years in children born
1978–2004
Paternal age associated with increased risk of dying
in early childhood due to an excess risk of fatal
congenital anomalies, malignancies and external
causes.
Adjusted for maternal age, parity, parental
education, year of birth.
High
Urhoj et al. (2017b),
Denmark
Cohort study 3492 cases
1 904 363 population
Paternal age:
ALL: ≥45 years AHR 1.55 (1.02–2.35)
Leukaemias overall: ≥45 years AHR 1.58
(1.07–2.32)
Paternal age 30–34
years
Paternal age associated with risk of ALL with 13%
higher HR for every 5 years increase in paternal age.
No firm conclusions for other specific cancer types
Adjusted for maternal age, child’s year of birth,
parental educational levels, parental ethnic origin and
maternal parity
High
Wunsch and Gourbin
(2002), Hungary
Cohort study 490 000 population
8300 cases/deaths
Paternal age:
25–34 years:
Neonatal mortality: OR 0.83 (0.76–0.89)
Post neonatal mortality: OR 0.99 (95% CI
0.95–1.16)
Paternal age 35–44
years
Live births and infant deaths from 1984–1988:
Early neonatal: up to 7 days of life
Neonatal: up to 28 days of life
Post neonatal: 28 days to 1 year of life
No adjustments described
Low
Yip et al. (2006),
Sweden
Cohort study 7844 cases with cancer:
Retinoblastoma n = 226
Leukaemia n = 1234
All CNS tumours n = 977
Astrocytoma n = 316
Wilm’s tumour n = 348
non-Hodgkin’s lymphoma
n = 218
Paternal age >40 years:
Retinoblastoma: AIRR 0.96 (0.47–1.97)
Leukaemia AIRR 1.14 (0.85–1.53)
CNS tumours AIRR 1.69 (1.21–2.35)
Astrocytoma AIRR 1.95 (1.10–3.45)
Wilm’s tumour AIRR 1.53 (0.89–2.65)
Non-Hodgkin’s lymphoma >40 years AIRR
1.09 (0.55–2.16)
Paternal age <25 years Children (<15 years) born 1961–2000 with
childhood cancer.
Adjusted for maternal age
High
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2015). Chudal et al. (2015) reported an association between younger
fathers and ADHD (highest risk associated with paternal age 20–24
years). Another study (D’Onofrio et al., 2014) reported an associ-
ation of ADHD with advanced paternal age, and the third study
(Hvolgaard Mikkelsen et al., 2016) found that there was a higher risk
of ADHD if both parents were very young.
Eating disorders Two studies reported on eating disorders (one of
high and one of low quality) (Racine et al., 2014; Javaras et al., 2017).
The high quality study reported an association between advanced
paternal age and eating disorders and also an association with anor-
exia nervosa (Javaras et al., 2017).
Bipolar disorders Six studies have assessed the risk of bipolar dis-
orders in offspring in relation to advanced paternal age, two study of
high quality (Brown et al., 2013; D’Onofrio et al., 2014) three of
medium quality (Frans et al., 2008; Chudal et al., 2014; Lehrer et al.,
2016) and one of low quality (Menezes et al., 2010). Both Brown
et al. (2013) and D’Onofrio et al. (2014) showed that advanced
paternal age was a risk factor for bipolar disorders in offspring.
Psychosis and psychotic-like symptoms Three studies, including two
case control studies of low quality (Gillberg, 1982; Foutz and Mezuk,
2015) and one study (El-Saadi et al., 2004) which reported results from
three different countries, assessed the association between paternal age
and psychosis and psychotic-like symptoms in offspring. Two of the
studies found an association between advanced paternal age and psych-
osis (El-Saadi et al., 2004; Foutz and Mezuk, 2015).
Conclusion: It is uncertain whether paternal age is associated
with an increased risk of other psychiatric conditions. Very low cer-
tainty of evidence (GRADE ⊕○○○)
Paternal BMI, height and/or weight at
childbirth and short-term outcomes for
offspring
Obstetric outcomes
Altogether 13 cohort studies (mostly of medium quality) have evalu-
ated the effect of paternal BMI, height, and/or weight on obstetric
outcomes, in most cases on BW of infants (Supplementary Table SII,
Table VII). All studies included in the systematic review had adjusted
for maternal factors such as maternal height and BMI. In nine studies
the influence of paternal height on BW of the children was studied. In
all studies the father´s height correlated significantly with BW of the
offspring. The effects of BMI, and the weight of the father at the time
of conception, or at the beginning of the pregnancy, on neonatal BW
were less clear. In one study from 2012, paternal BMI correlated sig-
nificantly with BW of the newborn, and biparietal diameter, head cir-
cumference and pectoral diameter in male offspring (Chen et al.,
2012). However, three of six studies did not find any association
between paternal BMI and BW of the babies (Table III). Four studies
evaluated the correlation between paternal weight at conception and
child BW. In three of these reports no association was found
(Wilcox et al., 1995; To et al., 1998; Nahum and Stanislaw, 2003).
Two studies compared paternal and child BW, with conflicting results
(Klebanoff et al., 1998; L’Abee et al., 2011).
Conclusion: Paternal height is probably associated with BW of the
offspring. Moderate certainty of evidence (GRADE⊕⊕⊕○). There may
be little or no association between paternal BMI/paternal weight and the
BW of the offspring. Low quality of evidence (GRADE⊕⊕○○).
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Paternal BMI, height and/or weight at childbirth
and long-term outcomes for offspring
Obesity
Paternal anthropometric measurements (BMI, height and/or weight)
available at the time of the child’s birth were studied in association
with childhood outcomes in 13 cohort studies (nine medium and four
high quality) and in one medium quality case control study
(Supplementary Table SII, Table VIII). In two of the studies paternal
height and weight were measured (Durmus et al., 2013; Heppe et al.,
2013) and in other studies this information was obtained from ques-
tionnaires or records. The outcome was BMI, body fat and/or weight
in 11 studies. Paternal anthropometrics at the time of the child’s birth
were associated with offspring BMI, weight and/or body fat mass in
all studies.
Conclusion: High paternal BMI and weight may be associated
with a modest increase in BMI, weight and/or body fat mass in off-
spring. Low certainty of evidence (GRADE⊕⊕○○).
ASDs and neurodevelopment
Paternal obesity was an independent risk factor for ASD in children
in one medium quality study (Suren et al., 2014) (Supplementary
Table SII, Table VIII). In the study of Yeung and co-workers (2017)
paternal obesity was associated with delays in personal-social func-
tioning, whereas maternal obesity was associated with delays in fine
motor development. Daraki and co-workers (2017) did not find any
association between paternal obesity and child neurodevelopment at
4 years of age (Supplementary Table SII, Table IV).
Conclusion: It is uncertain whether there is an association
between paternal obesity and ASD and neurodevelopment of the
child. Very low certainty of evidence (GRADE⊕○○○).
Paternal smoking at childbirth and short-
term outcomes for offspring
Obstetric outcomes
Preterm birth. Three cohort studies including more than 30 000 children
found no increased risk of PTB (<37 weeks) in children where fathers
smoked (Supplementary Table SIII, Table IX). Two of the studies were
adjusted for maternal smoking (Horta et al., 1997; Ko et al., 2014) and
in one cohort study analyses were performed on non-smoking mothers
(Andriani and Kuo, 2014). We included three studies in a meta-analysis
and found a slight but not significant effect of paternal smoking on PTB
(pooled estimate 1.16, 95% 1.00–1.35) (Fig. 14).
Conclusion: There may be little or no association between pater-
nal smoking and PTB. Low certainty of evidence (GRADE⊕⊕○○).
Low BW. Seven studies (six cohort and one case control), comprising
more than 60 000 children, investigated the association between pater-
nal smoking during preconception/pregnancy and BW (Supplementary
Table SIII, Table IX). In four cohort studies, all adjusted for maternal
smoking, no increased risk of LBW was observed in pregnancies where
fathers smoked (Horta et al., 1997; Andriani and Kuo, 2014; Ko et al.,
2014; Inoue et al., 2016).
Two cohort studies (Magnus et al., 1984; Martinez et al., 1994) and one
case control study (Zhang and Ratcliffe, 1993) explored the association
NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.926)
Maule (2007)
Larfors et al (2012)
Maule (2007)
Study
ID
Maule (2007)
1.08 (0.96, 1.21)
1.18 (0.76, 1.83)
1.08 (0.95, 1.23)
1.03 (0.71, 1.49)
AOR (95% CI)
0.93 (0.52, 1.67)
100.00
6.87
79.56
9.66
%
Weight
3.90
Decreased risk  Increased risk 
1.52 1.92
Figure 11 Forest plot describing the association between paternal age and risk for acute lymphoblastic leukaemia in the offspring.
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Table IV Studies on the association of paternal age with autism/ASDs in offspring.
Author, year,
country
Study design Number of children Result Outcomes Quality
Comment
AdjustmentsOutcome Reference group/
control
Systematic review and meta-analysis n = 2
Hultman et al. (2011),
Sweden
Meta-analysis
(For separate cohort
study see under original
papers below)
11 studies (including 12
cohorts) with paternal
age as exposure
Pooled estimates:
30–39 years 1.22 (1.05–1.42)
40–49 years 1.78 (1.52–2.07)
≥50 years 2.46 (2.20–2.76)
Paternal age ≤29 years Increased risk of autism with increased paternal
age
Medium
Wu et al. (2017),
China
Systematic review and
meta-analysis
27 studies (6 cohort
and 21 case control
studies) with paternal
age as exposure
Below reference points:
AOR 0.81 (0.73–0.89)
Above reference point:
AOR 1.55 (1.39–1.73)
Overall RR for each 10 year increase in
paternal age:
1.21 (1.18–1.24)
Reference point:
Midpoint paternal age
-age not mentioned
Compared to reference point, lower paternal
age was associated with reduced risk and
increased paternal age was associated with
increased risk of autism
Medium
Original articles n = 28
Ben Itzchak et al.
(2011), Israel
Cohort study 529 cases with ASD
Israeli Newborn data,
total population not
available (2004)
Paternal age in a cohort with ASD. No risk
estimate.
Paternal age 20–29 years The percentage of fathers in the older age
(30–40 years) was significantly higher in the ASD
cohort compared to the Israeli newborn data (P
< 0,01)
Low
Bilder et al. (2009),
USA
Case control 132 cases with ASD
13 200 controls
Paternal age:
OR 1.28 (0.54–3.03)
Paternal age 30–39 years No effect of paternal age (high or low)
Not adjusted for maternal age
Low
Buizer-Voskamp et al.
(2011), The
Netherlands
Case control 14 231 cases
(Autism n = 2262
Schizophrenia n = 2564
8284 Major depression
n = 8284
Bipolar disease n =
1121
9048 controls (56 924
controls in total)
Paternal age ≥40 years:
Autism: AOR 1.23 (1.01–1.50)
Paternal age 25–29 years Adjusted for maternal age <30 years and >30
years, ethnic background and average income of
the residential area
Medium
Burd et al. (1999a),
USA
Case control study 78 cases of autism
390 controls
A one-year decrease in the age of the father
decreased the risk of autism by 6% compared
to the control
OR 1.45 (0.90–2.45)
Paternal age
<20 or >30, 20–30 years
Matched controls
Increasing father’s age associated with increased
risk of autism
No adjusted risk estimate
Low
Byars and Boomsma
(2016), Denmark
Cohort study 10 703 cases with
autism (ASD)
20 586 cases with
schizophrenia
1 656 795 population
Paternal age:
26–30 years AHR 0.92 (0.86–0.98)
35–39 years AHR 1.10 (1.03–1.18)
40–44 years AHR 1.19 (1.06–1.33)
45–60 years AHR 1.2 (1.04–1.49)
Paternal age 31–34 years Adjusted for other parent’s age (see STable I) Medium
Croen et al. (2007),
USA
Case control 593 cases with autism
132 251 population
Paternal age:
35–39 years AOR 1.38 (1.04–1.84)
≥40 years AOR 1.52 (1.10–2.10)
With each 10 year increase in paternal age
ARR 1.34 (1.06–1.69)
Paternal age 25–29 years Adjusted for maternal age, birth order, gender,
date of birth, parental educational level, ethnicity
Medium
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D’Onofrio et al.
(2014), Sweden
Cohort study 2424 cases with autism
Psychosis, bipolar
disorder, suicide
attempts
900 337 population
Paternal age:
>45 years AHR 1.76 (1.36–2.28)
Paternal age 20–24 years Adjusted for maternal age, sex, year of birth,
parental education, history of psychiatric
hospitalization
High
Durkin et al. (2008),
USA
Cohort study 1251 cases with autism
253 347 population
Paternal age:
≥40 years AOR 1.4 (1.1–1.8)
With each 10 year increase in paternal age
AOR 1.3 (1.1–1.5)
Paternal age 25–29 years Adjusted for maternal age, birth order, gender,
maternal education, ethnicity, multiple birth,
gestational age, BW for gestational age
High
Frans et al. (2013),
Sweden
Case control 5936 cases with autism
30 923 controls
Paternal age:
45–49 years AOR 1.85 (1.47–2.31)
≥50 years AOR 2.23 (1.59–3.12)
With each 10 years RR 1.25 (95% CI 1.17,
1.31)
Paternal age 20–24 years Adjusted for maternal age, birth year, gender,
family history, educational level, country
Medium
Grether et al. (2009),
USA
Cohort study 23 311 cases with
autism 7 550 026
population
Paternal age:
50–54 years AOR 1.53 (1.32–1.77)
60–64 years AOR 2.05 (1.38–3.05)
With each 10 year increase in paternal age
(15–64 years) ARR 1.22 (1.18, 1.25)
Paternal age 25–29 years Adjusted for maternal age, child’s sex, birth
weight, ethnicity, education, parity, gestational
age, delivery method, birth year
High
Hultman et al. (2011),
Sweden
Cohort study 883 cases with autism
1 075 588 population
Paternal age:
30–39 years AOR 1.19 (1.00–1.42)
40–49 years AOR 1.42 (1.07–1.87)
≥50 years AOR 2.21 (1.26–3.88)
≥55 years AOR 4.36 (2.09–9.09)
With each 10 year increase in paternal age RR
1.21 (1.10, 1.34)
Paternal age <29 years Adjusted for maternal age, maternal country of
birth, birth weight, maternal history of
psychiatric illness, paternal country of birth,
paternal history of psychiatric illness, BW, being
small/large for gestational age, foetal distress,
SES, birth order, year of birth of the offspring
Medium
Idring et al. (2014),
Sweden
Cohort study 4746 cases with ASD
417 303 population
Paternal age:
25–28 years AOR 0.93 (0.90–0.96)
35–39 years AOR 1.07 (1.04–1.10)
55–59 years AOR 1.39 (1.29–1.50)
Paternal age 32 years Adjusted for maternal age (using generalized
additive models - GAMs), birth year, sex, parity,
parental psychiatric history, occupational class,
family income, maternal region of birth
High
King et al. (2009),
USA
Cohort study 18 731 cases with
autism
4 906 926 population
Paternal age:
Risk varies over time:
>40 years: lowest risk in 1992: RR 1.29
(1.03–1.60) to highest in 1995: RR 1.71
(1.41–2.08)
Paternal age <30 years Autism risk is analysed over multiple birth
cohorts
Not adjusted risk estimates
Medium
Lampi et al. (2013),
Finland
Case control 4713 cases with ASD
1132 with childhood
autism
1785 with Asperger’s
syndrome
1796 with pervasive
development disorder
(PDD)
18 777 controls
Paternal age:
Autism:
40–49 years AOR 1.6 (1.1–2.3)
Asperger:
40–49 years AOR 1.1 (0.5–2.2)
PDD:
40–49 years AOR 1.6 (0.8–3.2)
Paternal age 25–29 years Adjusted for maternal age, number of previous
births, weight for gestational age, intellectual
disability, maternal SES, paternal psychiatric
history.
Medium
Larsson et al. (2005),
Denmark
Case control 698 cases with autism
17 450 controls
Paternal age:
>39 years ARR 1.36 (0.96–1.93)
Paternal age 25–29 years Adjusted for perinatal factors, maternal age,
parental psychiatric history, socio-economic
characteristics
Medium
Continued
349
Paternalage,BM
I,sm
oking
and
outcom
e
for
children
Downloaded from https://academic.oup.com/humupd/article-abstract/24/3/320/4859613
by National Library of Health Sciences user
on 11 June 2018
........................................................................................
..........................................................................................................................................................................................................................................................
Table IV Continued
Author, year,
country
Study design Number of children Result Outcomes Quality
Comment
AdjustmentsOutcome Reference group/
control
Lauritsen et al. (2005)
Denmark
Cohort study 818 cases with autism
943 664 population
Paternal age:
40–44 years ARR 1.61 (1.19–2.18)
≥45 years: ARR 1.21 (1.78–1.86)
Paternal age 25–29 years Adjusted for maternal age, gender, calendar year
of diagnosis, paternal history of psychiatric
disease, parental country of birth
Medium
Lundstrom et al.
(2010), Sweden
Cohort (twin cohort) -
Sweden and UK
Sweden:
164 cases with ASD
11 122 population
UK:
66 cases with ASD
13 524 population
Paternal age in Sweden:
45–50 years AOR 1.90 (1.73–4.92)
≥51 years AOR 3.37 (1.02–11.14)
Paternal age in UK:
45–49 years AOR 1.66 (0.47–5.82)
≥51 years AOR 3.59 (0.37–34.46)
Paternal age 25–34 years Twin cohort
Adjusted for maternal age, zygosity and SES
Medium
Maimburg and Vaeth
(2006), Denmark
Case control 473 cases with infantile
autism
4730 controls
Paternal age:
>35 years AOR 0.9 (0.7–1.4)
Paternal age 25–29 years Adjusted for maternal age, maternal citizenship,
BW, gestational age, Apgar score, birth defect,
irregular foetal position
Medium
Mamidala et al.
(2013), India
Case control 471 cases with ASD471
controls
Paternal age:
>30 years AOR 1.05 (0.76–1.46)
Paternal age <30 years Adjusted for maternal age, gender, year of birth Medium
Parner et al. (2012),
Denmark
Cohort study (sibling
design)
9556 cases with ASD
1 311 736 children
Maternal age < 35 years and paternal age
35–39 years:
AHR 1.27 (1.19–1.35)
Maternal age < 35 years and paternal age ≥ 40
years:
AHR 1.44 (1.31–1.58)
Paternal age <35 years Combinations of parents’ ages: for mothers
younger than 35 years, the risk of ASD
increased with increasing father’s age group.
Adjusted for gestational age, birth weight, birth
order, sex, parental psychiatric history at birth
Medium
Quinlan et al. (2015),
USA (New York)
Cohort study 1589 cases with ASD
927 003 population
Paternal age:
≥35 years AOR 1.4 (1.08–1.68)
Paternal age <25 years Adjusted for parity, sex, race and ethnicity,
gestational age, maternal metabolic risk factor,
SGA. Not precise whether adjusted for maternal
age
Medium
Reichenberg et al.
(2006), Israel
Cohort study 319 cases with ASD
132 271 population
Paternal age:
40–49 years AOR 5.75 (2.65–12.46)
With each 10 year increase in paternal age RR
2.14 (1.44–3.16)
Paternal age 15–29 years Adjusted for year of birth, SES and maternal age Medium
Sandin et al. (2016),
Scandinavia
(Danmark, Norge,
Sweden), Western
Australia and Israel
Cohort study 30 902 cases with ASD
5 776 794 population
Paternal age and risk for ASD:
<20 years ARR 1.08 (0.92–1.27)
30–39 years ARR 1.05 (1.02–1.08)
40–49 years ARR 1.28 (1.22–1.34)
≥50 years ARR 1.64 (1.66–1.85)
Paternal age 20–29 years Joint effect of maternal and paternal age with
increasing risk for couples with increasing
differences in parental age.
Adjusted for site (country), sex, birth year,
maternal age
High
Sasanfar et al. (2010),
Iran
Case control study 179 cases with ASD
1611 controls
Paternal age:
≥40 years AOR 2.03 (1.10–3.73)
With each 10 year increase in paternal age a
29% increase in autism risk
Cohort study:
Paternal age 25–29 years
Case control study:
Paternal age 25–29 years
Adjusted for parental education, birth order,
sex, consanguinity, urbanism and province. Not
precise whether adjusted for maternal age
Low
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between BW and paternal smoking. Martinez et al. (1994) showed
that the number of cigarettes smoked by the father was associated
with lower BW in children with non-smoking mothers (test for linear-
ity P < 0.03). This was in line with Zhang, where paternal smoking
had a modest effect on BW, the mean BW being 30 grams lower in
pregnancies where the fathers smoked (Zhang and Ratcliffe, 1993). In
the study by Magnus, paternal smoking had no independent effect on
BW in the offspring (Magnus et al., 1984). We performed a meta-
analysis including four studies. A small but not significant effect of
paternal smoking on the incidence of LBW was found (pooled esti-
mate 1.10, 95% 1.00–1.21) (Fig. 15).
Conclusion: There appears to be little or no association
between paternal smoking and LBW. Low certainty of evidence
(GRADE⊕⊕○○).
SGA/intrauterine growth retardation. Two cohort studies investigated
SGA/ IUGR, defined as BW <10th percentile for gestational age and
sex (Horta et al., 1997; Ko et al., 2014), comprising more than
27 000 children in total (Supplementary Table SIII, Table IX). In
Horta et al. (1997) the adjusted risk of SGA/IUGR was significantly
increased in pregnancies with paternal smoking, AOR 1.33 (95% CI
1.05–1.68), while in the study by Ko et al. (2014) no significant asso-
ciation was found (AOR 1.12 (95% CI 0.90–1.40) for SGA/IUGR.
Figures were similar for paternal smoking in the first, second and third
trimesters (Ko et al., 2014). A meta-analysis including two studies
showed a pooled estimate of 1.21 (95% CI 1.03–1.44) (Fig. 16).
Conclusion: Paternal smoking may be associated with a small increase
in SGA/IUGR. Low certainty of evidence (GRADE⊕⊕○○).
Perinatal mortality. One cohort study of medium quality from
Lithuania (comprising 29 619 births) including 296 perinatal deaths
found an increased risk of perinatal death when fathers smoked
(AOR 1.72, 95% CI was not available) (Gaizauskiene et al., 2007)
(Supplementary Table SIII, Table IX). The probability of foetal and
NND was 0.009 in the offspring of fathers who smoked, in compari-
son with 0.005 in the offspring of non-smoking parents.
Conclusion: It is uncertain whether paternal smoking is associated
with perinatal death. Very low certainty of evidence (GRADE⊕○○○).
Birth defects
Eight studies (one cohort and seven case control) reported birth
defects in relation to paternal smoking before and during pregnancy
(Supplementary Table SIII, Table IX). The cohort study included 14 685
births for analysis and found no significant association between paternal
smoking and children with orofacial clefts, hydrocephalus, ventricular sep-
tal defect (VSD) and urethral stenosis (Savitz et al., 1991). There were
seven case control studies. These included a total of 1977 cases, where
four studies reported CHD (n = 1112) (Wasserman et al., 1996; Kuciene
and Dulskiene, 2010; Cresci et al., 2011; Deng et al., 2013), two studies
reported orofacial clefts (n = 780) (Krapels et al., 2006; Figueiredo et al.,
2015) and one study reported anorectal defects (n = 85 cases) (van
Rooij et al., 2010). Wasserman et al. (1996) also reported neural tube
defects (n = 264 cases) and limb reduction defects (n = 178 cases).
The three CHD studies showed a significantly increased risk asso-
ciated with paternal smoking with AOR ranging from 1.45 to 3.2
(Kuciene and Dulskiene, 2010; Cresci et al., 2011; Deng et al., 2013),
while Wasserman et al. (1996) showed no association (AOR 0.93,
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NOTE: Weights are from random effects analysis
.
.
.
.
Overall  (I-squared = 86.3%, p = 0.000)
Van Balkorn et al (2012)
Frans et al (2013)
Frans et al (2013)
Grether et al (2009)
Lauritsen et al (2005)
Grether et al (2009)
Grether et al (2009)
Tsuchiya et al (2008)
<=35y
Subtotal  (I-squared = 81.7%, p = 0.000)
Idring et al (2014)
Lauritsen et al (2005)
Idring et al (2014)
Subtotal  (I-squared = 74.5%, p = 0.000)
Lampi et al (2013)
Idring et al (2014)
Lundstrøm et al (2010)
Idring et al (2014)
Lundstrøm et al (2010)
Durkin et al (2008)
>45y
Frans et al (2013)
Lundstrøm et al (2010)
Byars et al (2016)
Frans et al (2013)
Lampi et al (2013)
Lundstrøm et al (2010)
Sandin et al (2016)
Lundstrøm et al (2010)
Larsson et al (2005)
Subtotal  (I-squared = 71.6%, p = 0.000)
Larsson et al (2005)
Van Balkorn et al (2012)
Byars et al (2016)
Sandin et al (2016)
Frans et al (2013)
Byars et al (2016)
Sandin et al (2016)
Idring et al (2014)
Durkin et al (2008)
Lauritsen et al (2005)
Grether et al (2009)
Grether et al (2009)
Maimburg et al (2006)
Grether et al (2009)
40–45y
Reichenberg et al (2006)
35–40y
Durkin et al (2008)
Lundstrøm et al (2010)
Frans et al (2013)
Van Balkorn et al (2012)
Grether et al (2009)
Buizer-Voskamp et al (2011)
Tsuchiya et al (2008)
Larsson et al (2005)
Lampi et al (2013)
Reichenberg et al (2006)
Idring et al (2014)
Buizer-Voskamp et al (2011)
Mamidala et al (2013)
Subtotal  (I-squared = 37.0%, p = 0.095)
ID
Maimburg et al (2006)
Lauritsen et al (2005)
Buizer-Voskamp et al (2011)
Lampi et al (2013)
Study
1.25 (1.20, 1.30)
2.67 (1.07, 6.68)
1.35 (1.02, 1.77)
1.21 (0.78, 1.86)
1.53 (1.32, 1.77)
1.41 (1.29, 1.54)
3.09 (1.17, 8.16)
1.37 (1.23, 1.53)
1.02 (0.98, 1.06)
1.22 (1.16, 1.28)
1.43 (1.33, 1.53)
1.60 (1.10, 2.30)
1.39 (1.29, 1.50)
0.81 (0.41, 1.58)
1.30 (1.23, 1.38)
3.37 (1.02, 11.14)
1.00 (0.90, 1.20)
1.23 (1.08, 1.41)
3.59 (0.37, 34.46)
1.10 (1.03, 1.18)
1.85 (1.47, 2.31)
1.21 (0.79, 1.85)
1.66 (1.49, 1.85)
1.66 (0.47, 5.82)
1.28 (0.96, 1.69)
1.14 (1.08, 1.21)
1.36 (0.96, 1.93)
2.38 (0.37, 15.40)
1.19 (1.06, 1.33)
1.05 (1.02, 1.08)
2.23 (1.59, 3.12)
1.20 (1.04, 1.49)
1.28 (1.22, 1.34)
1.07 (1.04, 1.10)
1.40 (1.10, 1.80)
1.61 (1.19, 2.18)
2.05 (1.38, 3.05)
0.90 (0.70, 1.40)
1.23 (1.17, 1.30)
1.62 (0.99, 2.65)
1.00 (0.90, 1.80)
1.90 (0.73, 4.92)
1.47 (1.24, 1.73)
2.16 (1.15, 4.04)
1.39 (1.30, 1.47)
1.23 (1.01, 1.50)
1.40 (1.10, 2.00)
5.75 (2.65, 12.46)
1.14 (1.10, 1.18)
1.07 (0.93, 1.23)
AOR (95% CI)
1.00 (0.70, 1.30)
1.35 (1.07, 1.70)
1.00 (0.89, 1.13)
1.70 (0.60, 4.60)
100.00
0.20
2.78
1.38
0.73
2.42
2.98
0.18
18.77
3.33
3.28
29.46
0.94
3.09
0.35
3.22
0.12
2.44
2.55
0.03
3.15
1.72
0.76
2.79
0.11
1.34
26.77
1.01
0.05
2.74
3.38
1.06
2.10
3.29
3.38
1.57
1.23
0.84
1.02
3.25
0.60
1.02
0.18
2.22
0.39
3.20
1.94
1.25
0.27
3.35
2.48
1.11
Weight
1.19
1.68
2.68
0.16
%
1.05 (0.94, 1.17)
1.15 (1.02, 1.30)
1.08 (0.89, 1.30)
1.20 (0.90, 1.50)
1.12 (1.07, 1.17)
2.28 (1.02, 5.11)
1.10 (0.88, 1.38)
1.05 (0.76, 1.46)
1.07 (1.02, 1.12)
2.66
2.02
1.51
3.30
0.25
1.72
25.01
Decreased risk  Increased risk 
1.029 34.5
Figure 12 Forest plot describing the association between paternal age and risk for autism/ASDs in the offspring.
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Table V Studies on the association of paternal age with schizophrenia and schizophrenia spectrum disorders in offspring.
Author, year,
country
Study design Number of
deliveries or
children
Result Outcomes Quality
Comment
AdjustmentsOutcomes (Risk estimates) Reference
group/ Control
Systematic reviews n = 3
Miller et al. (2011),
Finland
SR (6 cohort
and 6 case
control studies)
and MA
Cohort studies: 14 568
cases and 3 000 729
controls
Case control studies;
8733 cases and
1 945 092 controls
Paternal age
>50 years: RR 1.66 (1.46–1.89)
<25 years: RR 1.08 (1.02–1.14) in male offspring.
Paternal age 25–29
years
Adjusted for maternal age
Sub analyses on gender-stratified data
Medium
Torrey et al. (2009),
USA
MA (10 studies) 10 studies included Paternal age
>45 years: OR 1.38 (0.95–2.02)
>55 years: OR 2.22 (1.46–3.37)
NA Matched for city of birth, season of birth and parental
history of treatment for mental disorder
Low
Wohl and Gorwood
(2007), France
MA (8 studies) 8 out of 10 studies
were included
Paternal age
>54 years: OR 1.02 (2.03–17.12)
Paternal age 25–34
years
Adjusted for maternal age
Different age categories used as reference
Low
Original articles n = 19
Brown et al. (2002),
USA
Cohort study 12 094 individuals 73% response rate (146 of 170)
Risk for each 10-year increase in paternal age:
ARR 1.89 (1.08–3.32), Z = 2.22, P < 0.03
Paternal age 15–24
years
Adjusted for maternal age
Small study size (71 cases)
Includes both schizophrenia and other schizophrenia
spectrum diseases (SSD)
Low
Buizer-Voskamp et al.
(2011), The
Netherlands
Case control 14 231 cases
56 925 controls
Paternal age
>35 age: OR 1.27 (1.05–1.53)
Matched controls
Paternal age 25–29
years
Adjusted for maternal age, SES, and ethnic
background
Separate analyses for male and female offspring
Medium
Byars and Boomsma
(2016), Denmark
Cohort study 1 787 447 children 7 out of 15 risk ratios increased in the three age-difference groups
Estimates not given
NA 5 categories for schizophrenic disorders
U-shaped association
Low
Byrne et al. (2003),
USA
Case control 7704 cases
192 590 controls
Paternal age >50 years: Sex-specific estimates. Males with fathers
>55 years:
AIRR 2.10 (1.35–3.28).
Females with fathers >55 years:
AIRR: 3.53 (1.82–6.83)
Paternal age 20–24
years
Adjusted for maternal age, parental education,
wealth, marital status and family history of psychiatric
history
Medium
Dalman and Allebeck
(2002), Sweden
Case control 420 cases
857 controls
Paternal age
>45 years: AOR 2.8 (1.3–6.3)
Paternal age 20–24
years
Brief report. Adjusted for maternal age
No adjustment for paternal psychiatric illness
Low
Ek et al. (2015),
Sweden
Cohort study 3829 cases
2 589 502 individuals
Paternal age
>45 years: HR 0.93 (0.72–1.21)
35–39 years: HR 1.37 (1.18–1.58)
40–44 years: HR 1.81 (1.44–2.28)
Paternal age 25–29
years
Adjusted for offspring sex and maternal age
Small sample size in the oldest group
Low
Frans et al. (2011),
Sweden
Cohort study 120 758 individuals Paternal age
>55 years: AOR 1.95 (1.58–2.40)
Paternal age 20–24
years
Adjusted for maternal age, birth year Medium
Lehrer et al. (2016),
USA
Case control 5317 cases
7658 controls
Paternal age
>45 years: RRR 2.88 (2.65–3.13)
Paternal age 20–24
years
Adjusted for maternal age
Self-reporting of paternal age and clinical history
Medium
Malaspina et al. (2001),
Israel
Cohort 658 cases
89 722 controls
Paternal age
40–44 years: ARR 1.79 (1.25–2.57)
45–49 years: ARR 1.89 (1.24–2.88)
>50 years: ARR 2.60 (1.63–4.15)
Paternal age 20–24
years
Adjusted for maternal age, sex and ethnic group Low
McGrath et al. (2014),
Denmark
Cohort 2 894 688 people Paternal age
>45 years: IRR 1.54 (1.41–1.69)
Paternal age 25–29
years
The cohort was observed for 42.7 million person-
years
Medium
Continued
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Table V Continued
Author, year,
country
Study design Number of
deliveries or
children
Result Outcomes Quality
Comment
AdjustmentsOutcomes (Risk estimates) Reference
group/ Control
Naserbakht et al.
(2011), Iran
Case control 220 cases
220 controls
Birth rank comparisons: 35% versus 24% of the cases versus the
controls were in the third or upper birth rank (P = 0.01). Mean
age of fathers at birth in cases (30 ± 6.26 years) versus controls
(26.45 ± 5.64 years; P = 0.0001). Paternal age ≥32 years (at birth)
in cases versus controls: AOR 3.8 (1.80 to 4.27)
NA Paternal age category is not described
Matching for sex and maternal age
Low
Petersen et al. (2011),
Denmark
Cohort 2.2 million people Paternal age:
45–49 years: AIRR 1.39 (1.13–1.70)
50–54 years: AIRR 1.93 (1.49–2.50)
>55 years: AIRR 1.15 (1.12-1-20)
Paternal age 25–29
years
Adjusted for maternal age, proband sex, family
psychiatric history in father, mother and siblings
The risk of schizophrenia increased with increased
paternal age of the father´s first child
Medium
Sipos et al. (2004),
Sweden
Cohort 754 330 people For each 10 year increase in paternal age:
AHR 1.47 (1.23–1.76)
Paternal age 21–24
years
Separate analysis according to family history of the
disorder.
Adjusted for maternal age, BW, GA, parity and
plurality
Low
Sorensen et al. (2014),
Denmark
Cohort 176 454 men Cox regression to estimate the IRR of SSD
IRR: 1.32 (1.10–1.60) per 10 years increase in paternal age
Paternal age 25–29
years
SSD
Adjusted for maternal age, IQ, birth order and family
history of psychiatric disorders
Medium
Torrey et al. (2009),
USA
Cohort + MA
(10 studies)
168 + 88 cases
25 025 controls
Cohort of 88 cases:
Paternal age:
>35 years: OR 1.35 (0.88–2.06)
>40 years: OR 1.33 (0.75–2.37)
>45 years: OR 1.32 (0.48–3.63)
≥55 years:
MA: pooled OR 2.21 (1.46–3.37)
NA Matched for city of birth, season of birth and parental
history of treatment for mental disorder
Low
Tsuchiya et al. (2005),
Japan
Case control 99 cases, 381 controls Paternal age
29–31 years: AOR 2.08 (1.12–3.86)
>32 years: AOR 3.00 (1.49–6.04)
Test for trend P = 0.002
Paternal age < 25
years
Adjusted for age and gender of the subject, parity,
family history and maternal age.
Low
Wang et al. (2015),
Taiwan
Case series 1297 cases Inverted U-shaped association
Onset of schizophrenia was lowered by 1.5 years for paternal age
25–29 years and by 5.5 years for paternal age >55 years
Test for trend P = 0.04
Paternal age 21–24
years
Study of earlier onset among co-affected sib-pairs
with the same familial predisposition.
Adjusted for maternal age, gender, education in years
and parental education
Low
Wu et al. (2012),
China
Case control 351 cases
238 controls
351 patients with schizophrenia (167 males, 134 females)
Paternal age:
<25 years: OR 0.628 (0.350–1.127)
30–34 years: OR 2.660
(1.697–4.169)
>35 years: OR 10.183 (4.772–21.729)
Paternal age 25–29
years
Adjusted for participant´s sex, age and maternal age Low
Zammit et al. (2003),
Sweden
Cohort 2362 cases
50 087 individuals
For each 10-years increase in paternal age: AOR 1.3 (1.0–1.5); P
= 0.015
Paternal age: 55 years or more:
AOR: 3.8 (1.3–11.8)
Paternal age 15–24
years
Adjusted for maternal age, drug use, poor social
integration and place of upbringing.
BW, birth weight; GA, gestational age; HR, hazard ratio; IQ, intelligence quotient; IRR; incidence rate ratio, MA, meta-analysis; RRR, relative risk ratio; SSD schizophrenia spectrum diseases; SR, systematic review
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95% CI 0.58–1.5). Savitz et al. (1991) found no significant association
of paternal smoking and VSD (AOR 2.0, 95% CI 0.9–4.3).
We included six studies in a meta-analysis and found a positive
association between paternal smoking and CHD (pooled estimate
1.75 (95% CI 1.25–2.44) (Fig. 17).
There was also a positive association between paternal smoking
and orofacial clefts in both case control studies (AOR from 1.45 to
1.5) (Krapels et al., 2006; Figueiredo et al., 2015). However, there
was no significantly increased risk in the cohort study, with an APOR
1.7 (95% CI 0.5–6.0) (Savitz et al., 1991). Furthermore, there was a
NOTE: Weights are from random effects analysis
.
.
.
.
.
Overall  (I-squared = 86.3%, p = 0.000)
McGrath et al (2014)
McGrath et al (2014)
40–45y
Byrne et al (2003)
Byrne et al (2003)
Zammit et al (2003)
Malaspina et al (2011)
McGrath et al (2014)
Subtotal  (I-squared = 71.7%, p = 0.003)
Malaspina et al (2011)
Byrne et al (2003)
Petersen et al (2011)
Buizer-Voskamp et al (2011)
Petersen et al (2011)
Brown et al (2002)
McGrath et al (2014)
Wu et al (2012)
Tsuchiya et al (2005)
Dalman et al (2002)
Buizer-Voskamp et al (2011)
<35y
Ek et al (2015)
45-50y
Buizer-Voskamp et al (2011)
Dalman et al (2002)
Tsuchiya et al (2005)
35–39y
Ek et al (2015)
Zammit et al (2003)
Ek et al (2015)
Brown et al (2002)
Zammit et al (2003)
Subtotal  (I-squared = 83.2%, p = 0.000)
Sipos et al (2004)
Ek et al (2015)
Zammit et al (2003)
Sipos et al (2004)
Wu et al (2012)
>50
Sipos et al (2004)
Wu et al (2012)
Sipos et al (2004)
Byrne et al (2003)
Petersen et al (2011)
Brown et al (2002)
Malaspina et al (2011)
Malaspina et al (2011)
Petersen et al (2011)
Sipos et al (2004)
ID
Sipos et al (2004)
Petersen et al (2011)
Subtotal  (I-squared = 34.3%, p = 0.133)
Subtotal  (I-squared = 51.0%, p = 0.057)
Study
Malaspina et al (2011)
Subtotal  (I-squared = 69.3%, p = 0.000)
Petersen et al (2011)
Buizer-Voskamp et al (2011)
Byrne et al (2003)
Dalman et al (2002)
Byrne et al (2003)
Petersen et al (2011)
Sipos et al (2004)
Ek et al (2015)
McGrath et al (2014)
1.31 (1.23, 1.38)
1.19 (1.13, 1.26)
1.04 (1.00, 1.08)
1.22 (0.98, 1.51)
1.21 (1.03, 1.42)
3.80 (1.30, 11.80)
1.20 (0.90, 1.61)
1.34 (1.25, 1.44)
2.04 (1.53, 2.72)
1.89 (1.24, 2.88)
1.01 (0.93, 1.11)
1.39 (1.13, 1.70)
1.24 (1.07, 1.42)
1.09 (1.03, 1.14)
1.90 (0.30, 12.10)
1.05 (1.00, 1.09)
2.67 (1.70, 4.17)
2.08 (1.12, 3.86)
1.20 (0.80, 1.90)
1.05 (0.91, 1.22)
1.85 (1.41, 2.43)
1.27 (1.05, 1.53)
1.50 (0.90, 2.60)
3.00 (1.49, 6.04)
1.13 (1.01, 1.25)
1.20 (0.80, 1.80)
1.19 (0.71, 1.98)
3.60 (0.40, 33.90)
1.60 (0.80, 3.10)
1.41 (1.24, 1.60)
1.30 (0.56, 3.06)
1.38 (1.17, 1.64)
1.60 (1.00, 2.60)
2.32 (1.56, 3.44)
0.63 (0.35, 1.13)
2.08 (1.25, 3.46)
10.18 (4.77, 21.73)
1.66 (1.18, 2.34)
1.06 (0.93, 1.20)
0.99 (0.94, 1.04)
2.70 (0.60, 12.60)
1.56 (1.14, 2.13)
1.79 (1.25, 2.57)
1.93 (1.49, 2.50)
1.26 (0.93, 1.69)
AOR (95% CI)
1.31 (0.73, 2.36)
1.34 (1.23, 1.47)
1.40 (1.26, 1.56)
1.40 (1.27, 1.55)
2.60 (1.63, 4.15)
1.06 (1.01, 1.12)
1.31 (1.15, 1.49)
1.04 (0.94, 1.17)
1.61 (1.21, 2.13)
2.80 (1.30, 6.30)
1.03 (0.93, 1.14)
1.17 (1.10, 1.25)
4.62 (2.28, 9.36)
0.87 (0.80, 0.96)
1.54 (1.41, 1.69)
100.00
3.38
3.44
2.30
2.71
0.24
1.80
3.31
8.03
1.17
3.21
2.39
2.86
3.40
0.09
3.42
1.08
0.66
1.13
2.82
1.91
2.51
0.84
0.54
3.10
1.23
0.89
0.06
0.57
20.98
0.39
2.65
0.99
1.27
0.72
0.90
0.47
1.52
2.96
3.40
0.13
1.67
1.43
2.00
1.75
Weight
0.72
3.21
14.47
13.56
%
1.02
42.95
2.94
3.08
1.85
0.44
3.13
3.34
0.53
3.20
3.20
Decreased risk  Increased risk 
1.0295 33.9
Figure 13 Forest plot describing the association between paternal age and risk for schizophrenia/schizoaffective disorders in the offspring.
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Table VI Studies on the association of paternal age with other psychiatric disorders in offspring
Author, year,
country
Study design Number of deliveries or
children
Result Outcomes Quality
Comment
Outcomes (Risk estimates) Adjustments
Reference group/
Control
Adjustments
Original articles n = 15
Brown et al.
(2013), USA
Case control
study
94 cases
746 controls
Paternal age:
Per 10 year increment of paternal age:
AOR 1.04 (0.75–1.44)
Paternal age 20–29
years
Bipolar disorders
Measured as 10 years increase in paternal age.
Controls were matched on date of birth, sex
and residency
Adjusted for maternal age
Low
Burd et al.
(1999b), USA
Case control
study
92 cases
460 controls
Paternal age risk for Tourette:
β - 0.96, OR 0.909
Each additional year
of paternal age
decreased the risk of
Tourette syndrome
by 9.1%
Tourette syndrome
Controls matched for sex, year of birth and
month of birth
Low
Chudal et al.
(2014), Finland
Case control
study
1861 cases
3643 controls
Paternal age:
>50 years
AOR 2.84 (1.32–6.12)
30–34 years
AOR 1.35 (1.06–1.72)
Paternal age 25–29
years
Bipolar disorders
Adjusted for maternal age and additional
adjustment for parental psychiatric history,
parental educational level and place of birth
Medium
Chudal et al.
(2015), Finland
Case control
study
10 409 cases
39 125 controls
Paternal age:
<20 years
AOR 1.55 (1.11–2.18)
20–24 years
AOR 2.20 (1.07–1.34)
45–49 years
AOR 1.26 (1.01–1.58)
≥50 years
AOR 1.08 (0.73–1.58)
Paternal age 25–29
years
ADHD in singleton births during 1991–2005,
diagnosed 1995–2011
ADHD was associated with young fathers
Adjusted for maternal age, paternal psychiatric
history, maternal SES, maternal smoking during
pregnancy, previous birth, birth weight for
gestational age
Medium
D’Onofrio et al.
(2014), Sweden
Cohort study 2861 cases with ADHD
6819 cases with bipolar
disorder
2 615 081 population
Paternal age >45 years
ADHD:
HR 1.76 (1.36–2.28)
Sibling fixed-effects model: ADHD:
HR 13.13 (6.85–25.16)
Bipolar disorders:
HR 24.70 (12.12–50.31)
Psychosis:
HR 2.07 (1.35–3.20)
Paternal age 20–24
years
ADHD, bipolar disorders, psychosis
Adjusted for maternal age, sex, year of birth,
parental education, history of psychiatric
hospitalization. Also sibling-comparison analyses
High
Cohort study
(Denmark)
Denmark: 11 672 cases,
2,3 million population
Paternal age:
Denmark:
Paternal age 20–24
years
Psychosis
Adjusted for maternal age
Low to
medium
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El-Saadi et al.
(2004), Sweden
and Australia
Case control
(Sweden,
Australia)
Sweden: 134 cases and 8687
controls
Australia: 119 cases and 141
controls
35–39 years
AOR 1.14 (1.05–1.24)
50–54 years:
AOR 1.33 (1.33–2.53)
≥35 years:
Sweden:
AOR 2.42 (1.19–4.89)
Australia:
AOR 0.77 (0.24–2.46)
depending on
study group
Foutz and Mezuk
(2015), USA
Cohort study 924 cases
9282 population
Paternal age:
30–34 years:
AOR 0,63 (0.25–1.60)
≥35 years:
AOR 2.12 (1.08–4.16)
Paternal age 25–29
years
Psychotic-like symptoms
Adjusted for demographic characteristics, birth
order, lifetime history of depression, anxiety
and substance use disorders.
Low
Frans et al.
(2008), Sweden
Case control
study
13 428 cases
67 140 controls
Paternal age:
45–49 years
OR 1.14 (1.00–1.30)
50–54 years
OR 1.21 (1.00–1.48)
>55 years
OR 1.37 (1.02–1.84)
Paternal age 20–24
years
Bipolar disorders
Adjustment for maternal age, additional
adjustment for family history of psychotic
disorders, parity and socio-economic status
Medium
Gillberg (1982),
Sweden
Cohort study 155 cases:
Mental retardation 4
Psychosis 30
Psychogenic psychosis 2
Hyperkinetic disorders 3
Anorexia nervosa 5
Conduct disorders 38
Emotional disorders 64
Others 8
82 570 population
Paternal age:
No risk estimate
NA Psychiatric clinic attenders aged 3–19 years
during 1975
Psychotic children and adolescents tended to
have mothers and fathers who were older than
average
No adjustments
Low
Hvolgaard
Mikkelsen et al.
(2016), Denmark
Cohort study 12 294 cases
943 785 singletons
Paternal age:
31–35 years
AHR 0.9 (0.77–1.05)
≥35 years
AHR 0.74 (0.53–1.02)
Paternal age 26–30
years
ADHD
Adjusted for smoking, gender, maternal age
High
Javaras et al.
(2017), Sweden
Cohort study 2 276 809 population
Anorexia nervosa = 8137
Any eating disorder =16 405
Paternal age:
Anorexia nervosa:
20–24 years
AOR 0.91 (0.80–0.96)
≥45 years
AOR 1.32 (1.14–1.53)
Any eating disorder:
20–24 years
AOR 0.93 (0.87–0.98)
≥45 years
AOR 1.26 (1.13–1.40)
Paternal age 25–29
years
Eating disorders (anorexia nervosa and any
eating disorder). Adjusted for sex, birth order,
maternal age, country of birth, parental highest
education level, lifetime psychiatric and criminal
history
High
5317 cases Paternal age ≥45 years: Bipolar disorders with or without psychosis Medium
Continued
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Table VI Continued
Author, year,
country
Study design Number of deliveries or
children
Result Outcomes Quality
Comment
Outcomes (Risk estimates) Adjustments
Reference group/
Control
Adjustments
Lehrer et al.
(2016), USA
Case control
study
7658 controls Bipolar disorder with psychotic features:
RRR 1.939 (1.411–2.643)
Bipolar disorder without psychotic
features:
RRR 0.934 (0.536–1.543)
Paternal age 20–24
years
For schizophrenia and schizoaffective disorders
see Table 2c
Menezes et al.
(2010), Sweden
Cohort study 493 cases
754 330 population
Paternal age:
40–44 years
HR 1.85 (1.04–3.30)
45–49 years
HR 1.06 (0.39–2.83)
>50 years
HR 1.43 (0.43–4.76)
Paternal age 21–24
years
Bipolar affective disorders (BPAD)
Adjusted for maternal age, SES, family history of
psychosis and education
Risk of BPAD for each 10-years increase in
paternal age
Medium
Racine et al.
(2014), USA
Cohort study 1722 female twins aged 8–17
years, 11 cases
Paternal age:
No risk estimate.
Paternal age ≥40
years was coded as
reference group for
t-test comparisons in
categorical paternal
age models
Eating disorders
Advanced paternal age increased the risk for
eating pathology
Controlled for maternal age
Low
Saha et al.
(2009), Australia
Cohort study 33 437 singletons Paternal age 50 years:
OR for being in the lowest decile for
each neurocognitive variable was
significantly associated with elevated
paternal age for three of the
neurocognitive measures
Paternal age 20 years Neurocognitive development
Adjusted for maternal age, offspring sex,
mother’s race, weeks of gestation, child’s age at
testing, family and SES
Medium
ADHD, attention deficit hyperactivity disorder; BPAD, bipolar affective disorders.
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Table VII Studies on the association of paternal BMI, height and weight with obstetric outcomes in offspring.
Author, year,
country
Study
design
Number of
children
Results Outcomes Quality
Comments
Adjustments
Original articles n = 13
Cawley et al.
(1954), UK
Cohort
study
1028 children The height of the fathers was divided into six groups (under 60 inches up to
72 inches and over). BW of the child increased with increased height of father
(6.73, 6.91, 7.31, 7.35, 7.55, and 7.74 pounds respectively)
Birth weight (BW)
Adjusted for maternal height
Medium
Chen et al.
(2012), China
Cohort
study
889 children; 492
boys and 407 girls
Association between paternal BMI and foetal growth of male offspring:
BW (P = 0.013), biparietal diameter (P = 0.001), head circumference (P =
0.006), abdominal circumference (P = 0.003) and pectoral diameter (P = 0.043).
Paternal BMI was not associated with foetal growth of female offspring.
BW, newborn´s body shape and endocrine system
Multivariable regression analysis considering maternal BMI,
paternal and maternal age, hypertension during pregnancy,
maternal glycated serum protein, parity and gestational age as
confounding factors
Low
Klebanoff
et al. (1998),
Denmark
Cohort
study
Offspring to girls born
in Copenhagen
1959–1961.
n = 3130
Paternal BW was associated with infant BW (P = 0.002).
Association between paternal adult height and infant BW (P = 0.088)
Association between paternal BMI and infant BW (P = 0.049)
BW
Adjusted for maternal BW; maternal adult height, weight,
hypertension, diabetes, smoking, education, employment status, and
location of residence; child´s birth order and gender; other paternal
characteristics
Medium
L’Abee et al.
(2011), the
Netherlands
Cohort
study
2947 singletons born
2006–2007
Paternal BMI and paternal BW were not independent predictors for BW of
the offspring
BW
Adjusted for maternal factors
Medium
Lawlor et al.
(2007)
Australia
Cohort
study
7223 women and
their offspring
Paternal pre-pregnancy BMI: borderline significantly positive association with
birth weight standardized for sex and gestational age (regression coefficient
0.03)
BW
Paternal coefficient adjusted for maternal effect
Medium
Magnus et al.
(1984),
Norway
Cohort
study
3130 families Association between paternal weight and infant BW
(P < 0.01) and between paternal height and infant BW
(P < 0.05)
BW
Socio-economic status, educational attainment and paternal
smoking habit had no independent effects on infant BW
Medium
Morrison et al.
(1991),
Australia
Cohort
study
5989 children Paternal height was significantly associated with BW (P < 0.0007)
The increase of the BW was up to 152 g with increased height of the father
(ranging from 165 cm to 184 cm). Paternal BMI had no significant effect on the
BW of the child
BW
Adjusted for maternal BMI
Medium
Mutsaerts
et al. (2014),
Australia
Cohort
study
2264 children Paternal pre-pregnancy BMI had no influence on PTB AOR 0.99 (0.93–1.06)
or SGA AOR 0.96 (0.91–1.01)
In multivariable analysis paternal BMI did not significantly affect the outcomes
Spontaneous PTB, SGA
Adjusted for maternal factors
Medium
Nahum and
Stanislaw
(2003), USA
Cohort
study
241 children Association between paternal height and child BW (P = 0.02)
The addition in term BW attributable to each unit increase in paternal height
was 10 g/cm
No significant association between paternal weight and child BW
BW
Adjusted for maternal and pregnancy-specific factors
Low
Pritchard et al.
(1983), UK
Cohort
study
5834 children The SD scores for BW for taller men were constantly higher than for shorter
men. The average difference was 0.29 (approx. 115 g) for firstborn boys at 40
weeks gestation
BW
Adjusted for maternal height
High
Continued
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significant association between paternal smoking and anorectal mal-
formations (AOR 1.8, 95% CI 1.1–2.9) (van Rooij et al., 2010). Our
meta-analysis, including two studies of paternal smoking and orofacial
clefts, showed a positive association, with a pooled estimate of 1.51
(95% CI 1.16–1.97) (Fig. 18). However, none of the other birth
defects we explored showed a significant association with paternal
smoking.
Conclusion: Paternal smoking may be associated with a modest
increase in CHD and orofacial clefts. Low certainty of evidence
(GRADE⊕⊕○○).
Paternal smoking at childbirth and long-
term outcomes for offspring
Cancer
Five studies explored the association between paternal smoking dur-
ing pregnancy and cancers in offspring (Supplementary Table SIII,
Table X). Of these, three studies divided smoking into two sharply
distinguished classifications, smoking/non-smoking, but only reported
dose-response estimates (Ji et al., 1997; Sorahan et al., 2001; Pang
et al., 2003). In the use of cigarettes >5 pack-years, Ji et al. (1997)
found a significant association between paternal smoking and cancer
in offspring (AOR 1.7, 95% CI 1.2–2.5). Likewise Sorahan et al.
(2001) showed a significant association between smoking and cancer:
10 to 19 cigarettes per day (AOR 1.63, 95% CI 1.10–2.41) and
20–29 cigarettes per day (AOR 1.46, (95% CI 1.05–2.03). However,
Pang et al. (2003) did not show an association between cancer and
the father smoking >20 cigarettes per day. In the two studies with
the smoking/non-smoking dichotomy, Sorahan and Lancashire (2004)
showed a significant association between smoking and cancer in off-
spring (AOR 1.28, 95% CI 1.15–1.42), while John et al. (1991) did
not. Childhood acute leukaemia and brain tumours are dealt with in
the sections below, while paternal smoking was not associated with
any of the specific cancers in any of the studies.
Conclusion: Paternal smoking during pregnancy may be asso-
ciated with a modest increase in cancer in offspring. Low certainty of
evidence (GRADE⊕⊕○○).
Acute childhood leukaemia. Out of 19 original studies, two were of
medium and 17 of low quality (Supplementary Table SIII, Table X).
Studies rated as low quality included only a few cases, and the infor-
mation on paternal smoking in the preconception period and during
pregnancy was collected retrospectively from mothers several years
after birth. The majority of studies found no association between
maternal smoking and childhood leukaemia, hence they did not adjust
for maternal smoking in the analyses of paternal smoking.
Acute lymphoblastic leukaemia. Two meta-analyses on paternal smok-
ing and ALL have been published (Liu et al., 2011; Milne et al., 2012).
Milne et al. (2012) included both a meta-analysis and original data in
their paper (Table X). All 10 studies included in the meta-analysis by
Milne et al. (2012) were also included in the meta-analysis by Liu
et al. (2011), except for the original data: the latter meta-analysis
included 18 case control studies. Thirteen studies explored paternal
smoking during the preconception period (AOR 1.25, 95% CI
1.08–1.46) and eight studies during pregnancy (AOR 1.24, 95% CI
1.07–1.43). Their dose–response analysis estimated a higher risk
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Table VIII Studies on the association of paternal BMI, height and weight with long-term outcomes in offspring
Author, year,
country
Study
design
Number of
children
Results Outcomes Quality
Comments
Adjustments
Original studies n = 14
Catalano et al.
(2009), USA
Case
control
study
89
children
(52 from NGT
and 37 from
GDM
pregnancies
Paternal weight at the time birth was greater in children in tertile 3 of weight
percentiles compared to children in tertile 1 at follow-up at 8.8 ± 1.8 years
No difference in paternal BMI at the time of child’s birth in relation to tertiles of
percentage body fat of the child
Childhood weight and body fat (measured by dual energy X-ray
absorptiometry) at follow-up
Reference: Centers for Disease Control and Prevention (CDC) weight
and body fat percentiles
Maternal obstetrical data, paternal anthropometric data and neonatal
birth data was included to best determine which combination of perinatal
factors best modelled the risk of adiposity in child
Maternal pre-pregnancy BMI was the strongest predictor of childhood
obesity
Medium
Cawley et al.
(1954), UK
Cohort
study
1028 children Infant weight was more highly correlated with height of mother than father.
Correlation of infant height and weight at 24 months; mother 0.21, father 0.13
Weight of 625 children with observations at all intervals (6, 9, 12 and 24
months)
Adjusted for maternal height
Medium
Daraki et al.
(2017),
Greece
Cohort
study
772 children Paternal obesity not associated with child neurodevelopment at 4 years of age Child neurodevelopment
Adjusted for maternal BMI
Medium
Davey Smith
et al. (2007),
UK
Cohort
study
4654 children The association between paternal BMI and offspring BMI at 7.5 years of age:0.202
standardised age and sex adjusted coefficient (0.175–0.229), similar to maternal
BMI
Childhood BMI
Standardised regression coefficients age and sex adjusted
Sensitivity analysis for non-paternity performed
Maternal and paternal BMI were included in the same model.
High
Durmus et al.
(2011), The
Netherlands
Cohort
study
5674 children Pre-pregnancy paternal BMI was strongly associated with childhood overweight at
the age of 4 years
The main effects of maternal BMI on childhood BMI were stronger than the main
effects of paternal BMI (P < 0.001; and P = 0.013, respectively)
As compared to children from parents with normal BMI, children from two obese
parents had an increased risk of overweight at the age of years, OR 6.52
(3.44–12.38)
Childhood height, weight and BMI.
Maternal BMI had a significantly stronger effect on childhood BMI
Adjusted for maternal BMI
High
Heppe et al.
(2013), The
Netherlands
Cohort
study
3610 children Higher paternal BMI associated with higher risk of preschool overweight:
OR 1.35 (1.19–1.53)
Preschool overweight
Values reflect the OR and 95% CI for each parental or child
characteristics that remained in the backward selection model. Maternal
pre-pregnancy BMI in the model
High
Jaaskelainen
et al. (2011),
Finland
Cohort
study
(NFBC
1986)
4788 children Paternal pre-pregnancy obesity strongly predicted overweight:
At 16 years of age:
Father–son OR 3.17 (1.70–5.92)
Father–daughter OR 5.58 (3.09–10.07)
If both parents obese, overweight of the child at 16 years:
Sons OR 5.66 (3.12–10.27)
Daughters OR 14.84 (7.41–29.73)
Childhood overweight
Long-term overweight of both parents had a greater impact on the risk of
offspring overweight than parental weight gain from normal weight to
overweight/obesity during the 16-year follow-up period
High
Lawlor et al.
(2007),
Australia
Cohort
study
7223 children The increase in standardized offspring BMI at age 14 for a one SD increase in
paternal BMI was 0.239 SD (0.197–0.282)
Childhood BMI
The maternal-offspring BMI association was stronger than the paternal-
offspring BMI association
Paternal coefficient adjusted for maternal effect
Medium
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Table VIII Continued
Author, year,
country
Study
design
Number of
children
Results Outcomes Quality
Comments
Adjustments
Lawlor et al.
(2008), UK
Cohort
study
4091 children As assessed at 9 to 11 years of age, mean difference in offspring sex- and age-
standardized fat mass z-score per 1 SD BMI 0.24 (0.22–0.26) for maternal BMI
versus 0.13 (0.11–0.15) for paternal BMI
Offspring fat and lean mass (measured by dual energy X-ray
absorptiometry)
Adjusted for maternal BMI
Maternal effect size association was larger
Medium
Linabery et al.
(2013), USA
Cohort
study
912 children Infants of obese fathers had BMI growth curves distinct from those of normal
weight fathers. The p value for the global association between paternal BMI
category and infant BMI growth curves (birth-3.5 years) from joint mixed effect
model was 0.02
Infant BMI
Maternal BMI has a stronger influence on BMI growth than paternal BMI
Missing exposure (11% maternal and 26% paternal BMIs) and covariate
data were assumed to be missing at random and imputed, outcomes
were not imputed
Adjusted for maternal BMI in the joint model
Medium
O’Callaghan
et al. (1997),
Australia
Cohort
study
4062 children Paternal BMI is independent predictor of severe and moderate obesity at 5 years of
age.
Paternal BMI percentiles 85–94:
Severe obesity RR 2.8 (1.8–4.5)
Moderate obesity RR 1.0 (0.6–1.5)
Paternal BMI percentiles >95:
Severe obesity RR 2.0 (1.1–3.6)
Moderate obesity RR 2.1 (1.4–3.3)
Offspring obesity (BMI class)
Reference category: paternal BMI percentiles 15–84
Medium
Reilly et al.
(2005), UK
Cohort
study
7758 children Paternal obesity was associated with the risk of obesity in children at 7 years of age.
Final model AOR: Father (BMI > 30) 2.54 (1.72–3.75) compared to both parents
with
BMI < 30.
As compared to children from parents with normal BMI, children from two obese
parents had an increased risk of overweight at the age of 4 years: OR 6.52
(3.44–12.38)
Offspring obesity based on BMI
Maternal and paternal BMI were entered in the logistic regression models
with risk of severe or moderate obesity as the dependent variable
Medium
Suren et al.
(2014),
Norway
Cohort
study
92 909 children ASD in children at the age of 4.0–13.1 (mean 7.4) years:
Paternal BMI > 30: versus BMI < 25
AOR 1.73 (1.07–2.82)
Asperger disorder in children aged ≥7 years:
Paternal BMI > 30 versus BMI < 25
AOR 2.01(1.13–3.57)
ASDs
Adjusted for maternal BMI
Medium
Yeung et al.
(2017), USA
Cohort
study
4821 children Increased risk of failing the personal-social domain in children up to 3 years of age
Paternal BMI > 30 compared with children of normal weight fathers
AOR 1.71 (1.08–2.70)
Children whose parents both had BMI ≥35 were likely to additionally fail the
problem-solving domain
Delays in childhood development
Adjusted for maternal obesity
Medium
ASD, autism spectrum disorder; GDM, gestational diabetes mellitus; NGT, normal glucose tolerance; RR, relative risk;
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Table IX Studies on the association of paternal smoking with obstetric outcomes and birth defects in offspring
Author, year,
country
Study design Number of deliveries or
children
Result Quality
Outcomes (Risk estimates) Comment
Adjustments
Obstetric outcomes n = 8
Andriani and Kuo
(2014), Taiwan
Cohort 1993–2007 3789 children
71.5% paternal smoking with non-
smoking mothers
2.4% only mother smoking
LBW
Only father smoking during pregnancy
AOR 0.89 (0.51–1.54)
1–10 cig/day AOR 0.81 (0.58–1.14)*
11–20 cig/day AOR 0.66 (0.46–0.94)*
≥20 cig/day AOR 2.09 (1.38–3.17)*
PTB
Only father smoking during pregnancy
AOR 1.16 (0.78–1.71)
1–10 cig/day AOR 0.51 (0.34–0.75)*
11–20 cig/day AOR 0.78 (0.55–1.11)*
≥20 cig/day AOR 2.11 (1.38–3.23)*
Questionnaires to both parents Adjusted for sex, birth order,
maternal age, father’s education, maternal employment status,
parental BMI, household income, urban/rural residence
*Only adjusted for birth order
Medium
Gaizauskiene et al.
(2007), Lithuania
Birth Registry study
2002
296 Perinatal death
(199 stillborn + 97 died within the
first six days after delivery)
Total cohort N = 29 619
Perinatal death
Paternal smoking
AOR 1.6 (1.4–2.2)
Paternal smoking without maternal smoking
AOR 1.72 (no CI)
Confounders 45 parameters
Maternal age < or ≥36 years
Education, marriage/cohabiting
Low
Horta et al.
(1997), Brazil
Cohort 1993 5166 singleton live birth
2237 (43.3%) paternal smoking
LBW: AOR 1.18 (0.94–1.48)
PTB: AOR 1.25 (0.99–1.57)
IUGR: AOR 1.33 (1.05–1.68)
Mothers interviewed soon after delivery by trained interviewers
Adjusted for social class, maternal schooling, parity, birth
interval, prior LBW, maternal height, number of antenatal care
visits and for maternal smoking
Medium
Inoue et al.
(2016), Japan
Prospective hospital cohort
study
1997–2010
Total 21 855 newborn
Present study 16 396
Non-participants 5459 (25%)
Smoking:
5905 Mother no/Father yes
LBW
Smoking only fathers
502 children with LBW
AOR 1.07 (0.94–1.22)
Birth after GA 37 weeks
Mothers interviewed in 1. trimester
Adjusted for maternal smoking, paternal smoking (or four types
of combination of interaction effect), maternal age, paternal
age, maternal BMI, maternal occupational status, parity, sex
Medium
Ko et al. (2014),
Taiwan
Birth Cohort study
2005–2006
Total 24 200 children
Interview rate 87.8%
Included 21 248 children
LBW, PTB, SGA
Preconception >20 cigarettes per day:
PTB, n = 101/1158 (8.7%)
AOR 1.07 (0.84–1.35)
LBW, n = 84/1158 (7.3%)
AOR 1.14 (0.87–1.27)
SGA, n = 114/1158 (9.8%)
AOR 1.12 (0.90–1.40)
Interview 6 months post-partum (mothers)
Adjusted for maternal age, nationality, education, parity, total
weight gain during pregnancy, gender of infant, multiple birth
and maternal smoking in the same period
Similar results for smoking in 1. or 2–3 trimester
Medium
Magnus et al.
(1984), Norway
Cohort study
1967–1979
3130 singletons
11 175 pairs of like-sexed twins
born 1915–1960
Singletons born 1967–1979
Birth weight
Correlation matrix
Paternal smoking
Regression coefficients (+/− SE)
Bivariate regression −48 (8.9) P < 0.01
Paternal height and weight, Maternal height and weight,
paternal and maternal education, SES, maternal smoking
Correlation matrix
Low
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Table IX Continued
Author, year,
country
Study design Number of deliveries or
children
Result Quality
Outcomes (Risk estimates) Comment
Adjustments
Multiple regression −4.9 (9.3) NS
Martinez et al.
(1994), USA
Cohort study 1596 eligible children
350 refused (22%)
1219 respondents
191 father smoking
992 mother non-smoking
907 non-smoking mothers in
multiple regression analyses
Birth weight
Paternal with non-smoking mother:
None: 3602 g ± 401
1–10:3573 g ± 388
11–20:3520 g ± 382
>20:3514 g ± 428
P for linearity 0.026
88 g adjusted BW difference
P for linearity = 0.026
Hospital data at birth + questionnaire ≤1 months after birth by
parents
Multiple regression analysis for non-smoking Mothers.
Adjusted for GA, birth order, ethnicity, maternal and
paternal education, maternal age, sex
Medium
Zhang and
Ratcliffe (1993),
Shanghai
Case control
1986–1987
1785 full term singleton live born
normal infants of
non-smoking mothers
1033 exposed to paternal smoking
752 non-exposed
Birth weight
3236 g versus 3262 g
Birth weight diff 26 g (NS)
Multiple linear regression
30 g (95% CI = −7.66)
Pretested in-hospital interview to mothers after delivery
Adjusted for parity, maternal age, gestational age, maternal
occupation.
Modestly adverse effect on birth weight
Low
Birth defects n = 8
Cresci et al.
(2011), Italy
Case control
2008–2010
360 cases
360 controls
CHD
Paternal smoking OR 1.7(1.1–2.6)
Paternal smoking ≥15 cigarettes per day:
OR 2.1 (1.3–3.5)
Questionnaires to both parents. Matched for age range
Unconditional regression adjusted for potential confounders but
not specified
Maternal smoking insignificant but not directly adjusted for
Low
Deng et al. (2013),
China
Case control
2010–2011
284 cases
422 controls
Subgroups
Light smoking 1–9 cig/day
Medium 10–19 cig/day
Heavy ≥ 20 cig/day
Non-syndromic CHD
Paternal smoking during peri-conception period
(3 months before pregnancy and first trimester)
and non-smoking mothers
No avoidance behaviour:
Septal defects: 37 cases/46 controls
AOR 2.52 (1.39–4.59)
Cono-truncal defects: 36 cases/46 controls
AOR 3.22 (1.75–5.93)
Other outcomes listed but less than 20 cases
Maternal face-to-face interview Adjusted for residence, age,
education, pre-pregnant BMI, alcohol use, folic acid use,
paternal alcohol and family history of CHD
Low
Figueiredo et al.
(2015), USA
Prospective case control
Democratic Republic of
Congo, Vietnam, Philippines,
Honduras
430 cases
754 controls
Fathers smoking
173 cases
245 controls
Orofacial cleft
Paternal smoking 3 months before and during
pregnancy
AOR1.5 (1.1–1.9)
Interview of mothers
Age <3 years
Adjusted for sex, parental employment and education and age,
location at birth rural/city, country
Maternal smoking infrequent - only 1.4–1.9%
Medium
Krapels et al.
(2006), The
Netherlands
Case control 350 cases
222 controls
Fathers smoking >10 cig/day
62 Cleft lip +/− cleft palate
17 Cleft palate only
Orofacial cleft
Univariate analyses paternal smoking:
>10 cigarettes per day:
Cleft lip with or without cleft palate: OR 1.5
(1.0–2.4)
Cleft palate only: OR 1.8 (0.9–3.5)
Questionnaires to both parents
Follow-up two years after the
peri-conception period
Multivariate analyses are not shown for paternal smoking but
was not significant
Low
Case control register study 261 newborns Congenital heart septal defects Low
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associated with an increased number of cigarettes a day (CPD), >20
CPD (AOR 1.30; 95% CI 1.09–1.55) (Liu et al., 2011). Milne et al.
(2012) also found a significantly increased risk of ALL when fathers
smoked around the time of conception (AOR 1.15, 95% CI 1.06–1.24).
For >20 CPD their meta-analysis included seven studies (AOR 1.44,
95% CI 1.24–1.68).
Three low quality studies out of the 17 original studies in this sys-
tematic review were not included in the meta-analysis. Castro-
Jimenez and Orozco-Vargas (2011) included 85 matched pairs and
found AOR 1.93 (95% CI 1.06–3.54), Farioli et al. (2014) included
only risk estimates according to the following categories 1–10 CPD
(AOR 0.86, 95% CI 0.58–1.26) and >10 CPD (AOR 0.74 (95% CI
0.51–1.05). The Metayer et al. (2013) study was an expansion of
Chang’s (Chang et al., 2006) (included in both meta-analyses) and
found an AOR 0.94 (95% CI 0.69–1.27). Based on the meta-analyses,
paternal smoking was associated with a 15–25% increased risk of
ALL.
Conclusion: Paternal smoking may be associated with a slightly higher
risk of childhood ALL. Low certainty of evidence (GRADE⊕⊕○○).
Acute myeloid leukaemia. Twelve original studies (two of medium qual-
ity and 10 of low quality) evaluated the outcome of paternal smoking
on acute myeloid leukaemia (AML) (Supplementary Table SIII, Table X).
The meta-analysis included eight studies and two unpublished reports.
Figures for paternal smoking prior to conception were AOR 1.19 (95%
CI 1.00–1.41) and during pregnancy AOR 1.28 (95% CI 1.05–1.57). All
original studies in our systematic review are included in the meta-
analysis.
Conclusion: There appears to be little or no association between
paternal smoking and childhood AML. Low certainty of evidence
(GRADE⊕⊕○○).
Brain tumours. Fourteen studies explored the association between
paternal smoking prior to and during pregnancy, and brain tumours
(Supplementary Table SIII, Table X). All were included in our meta-
analysis, which showed a significant association between paternal
smoking and brain tumours (pooled estimate 1.12, 95% CI
1.03–1.22) (Fig. 19).
Conclusion: Paternal smoking may be associated with a small
increase in childhood brain tumours. Low certainty of evidence
(GRADE⊕⊕○○)
Cardio-metabolic outcomes. Nine cohort studies of medium quality
assessed paternal smoking and cardio-metabolic outcomes in off-
spring (Supplementary Table SIII, Table X). Five studies examined
BMI (Leary et al., 2006; Kwok et al., 2010; Durmus et al., 2011;
Howe et al., 2012; Florath et al., 2014), three studies looked at blood
pressure and hypertension (Brion et al., 2007; de Jonge et al., 2013;
Taal et al., 2013), and one study explored DM type 1 (Toschke et al.,
2007). Due to the heterogeneity of the studies, meta-analyses could
not be performed for any of these outcomes.
The BMI of children was measured at various ages in the five stud-
ies and the results diverged. In two of the studies, no linear associa-
tions were observed between paternal smoking and BMI (Durmus
et al., 2011; Howe et al., 2012). However, three studies showed a
negative linear association between paternal smoking and BMI in chil-
dren aged 7 to 10 years (Leary et al., 2006; Kwok et al., 2010;
Florath et al., 2014).
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Brion et al. (2007) and Taal et al. (2013) showed no association
between paternal smoking and diastolic or systolic BP in offspring in
the adjusted models, neither did de Jonge et al. (2013) show any
association between paternal smoking and hypertension in daughters.
Toschke et al. (2007), in two combined cohorts, showed significantly
lower risk estimates of DM type 1 in children where fathers smoked
during pregnancy (AOR 0.44, 95% CI 0.25–0.75).
Conclusion: It is uncertain whether there is any association
between paternal smoking and BMI in offspring. Very low certainty of
evidence (GRADE⊕○○○). There may be little or no association
between paternal smoking and blood pressure in offspring. Low cer-
tainty of evidence (GRADE⊕⊕○○). It is uncertain whether there is
any association between paternal smoking and DM type 1 in the off-
spring. Very low certainty of evidence (GRADE⊕○○○).
Neuro-developmental outcomes
Six cohort studies explored the association between paternal
smoking and neuro-developmental outcomes, out of which three
cohort studies studied ADHD (Nomura et al., 2010; Langley et al.,
2012; Zhu et al., 2014) (Supplementary Table SIII, Table X). All
studies were heterogeneous regarding child age, questionnaires
used for the parents, and outcome measures. Two of the studies
found a significant association between paternal smoking and
ADHD (AOR ranging from 1.29–1.42) (Langley et al., 2012; Zhu
et al., 2014), while Nomura et al. (2010) found no significantly
increased risk (AOR 0.31, 95% CI 0.06–1.92). In Langley et al.
(2012) and Zhu et al. (2014) the children were 7 and 8 years of
age, while the children in Nomura et al. (2010) were only 3 and 4
years old. None of the other studies found any associations
between paternal smoking and neuro-developmental outcomes,
except Brion et al. (2010), who found a significant association
between paternal smoking and conduct/externalizing problems
(AOR 1.12, 95% CI 1.02–1.24).
Conclusion: Paternal smoking may be associated with a small
increase in ADHD. Low certainty of evidence (GRADE⊕⊕○○). It is
uncertain if there is any association between paternal smoking and
other neuro-developmental outcomes. Very low certainty of evi-
dence (GRADE⊕○○○).
Discussion
General discussion
In this systematic review and meta-analysis we have tried to summar-
ize the evidence for the effect of paternal factors on perinatal and
paediatric outcomes. Paternal factors investigated in the present
paper were paternal age and life-style factors, in particular smoking
and BMI/height/weight of the fathers at time of conception. Other
exposures, such as male subfertility and teratogenic drugs, have not
been included in the present systematic review. Table XI presents a
summary of the findings from the meta-analyses.
NOTE: Weights are from random effects analysis
.
Overall  (I-squared = 0.0%, p = 0.654)
Andriani (2014)
Subtotal  (I-squared = 0.0%, p = 0.654)
Study
Ko (2014)
Horta (1997)
.
ID
1.16 (1.00, 1.35)
1.16 (0.78, 1.71)
1.16 (1.00, 1.35)
1.07 (0.84, 1.35)
1.25 (0.99, 1.57)
AOR (95% CI)
100.00
15.07
100.00
%
41.25
43.67
Weight
Decreased risk  Increased risk 
1.585 1.71
Figure 14 Forest plot describing the association between paternal smoking and risk for PTB.
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NOTE: Weights are from random effects analysis
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Overall  (I-squared = 0.0%, p = 0.743)
ID
Andriani (2014)
Ko (2014)
Inoue (2016)
Horta (1997)
Study
.
Subtotal  (I-squared = 0.0%, p = 0.743)
1.10 (1.00, 1.21)
AOR (95% CI)
0.89 (0.51, 1.54)
1.14 (0.87, 1.27)
1.07 (0.94, 1.22)
1.18 (0.94, 1.48)
1.10 (1.00, 1.21)
100.00
Weight
2.99
25.53
53.74
17.73
%
100.00
Decreased risk  Increased risk 
1.51 1.96
Figure 15 Forest plot describing the association between paternal smoking and risk for LBW in offspring.
NOTE: Weights are from random effects analysis
.
Overall  (I-squared = 8.3%, p = 0.296)
ID
Subtotal  (I-squared = 8.3%, p = 0.296)
Ko (2014)
.
Horta (1997)
Study
1.21 (1.03, 1.44)
AOR (95% CI)
1.21 (1.03, 1.44)
1.12 (0.90, 1.40)
1.33 (1.05, 1.68)
100.00
Weight
100.00
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47.17
%
Decreased risk  Increased risk 
1.595 1.68
Figure 16 Forest plot describing the association between paternal smoking and risk for SGA in offspring.
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NOTE: Weights are from random effects analysis
.
Overall  (I-squared = 61.4%, p = 0.024)
ID
Deng (2013)
Wasserman (1996)
Cresci (2011)
Study
Subtotal  (I-squared = 61.4%, p = 0.024)
Deng (2013)
.
Kucienè (2010)
Savitz (1991)
1.75 (1.25, 2.44)
AOR (95% CI)
3.22 (1.75, 5.93)
0.93 (0.58, 1.50)
1.70 (1.10, 2.60)
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2.00 (0.90, 4.30)
100.00
Weight
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%
100.00
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Decreased risk  Increased risk 
1.169 5.93
Figure 17 Forest plot describing the association between paternal smoking and risk for CHDs in offspring.
NOTE: Weights are from random effects analysis
.
Overall  (I-squared = 0.0%, p = 0.847)
ID
Savitz (1991)
Subtotal  (I-squared = 0.0%, p = 0.847)
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Figure 18 Forest plot describing the association between paternal smoking and risk for orofacial clefts.
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Table X Studies on the association of paternal smoking with long-term outcomes in offspring.
Author, year,
country
Study design Number of deliveries
and children
Result Outcomes
Adjustments
Quality
assessmentOutcomes
(Risk estimates)
Cancer
Acute childhood leukaemia
Meta-analyses n = 3
Metayer et al.
(2016), USA
SR with meta-analysis
Pooled analyses of
CLIC studies
Childhood Leukaemia
International Consortium
(CLIC) studies:
Meta-analyses including
6–9 CLIC studies and
3–4 Non-CLIC studies
Pooled analysis of 12 case
control studies with 1330
AML
13 169 controls
AML
Paternal smoking during preconception period
MA (CLIC+non-CLIC): AOR 1.19 (1.00–1.41)
Pooled CLIC studies: AOR 1.18 (1.01–1.38)*
Paternal smoking during pregnancy
MA (CLIC+non-CLIC): AOR 1.28 (1.05–1.57)
Pooled CLIC studies: AOR 1.24 (1.06–1.46)*
Paternal ever smoking
MA (CLIC+non-CLCI): AOR 1.18 (0.92–1.51)
Pooled CLIC studies: AOR1.34 (1.11–1.62)*
Interview with mothers and/or fathers, age <15 yrs
Adjusted for age, sex, ethnicity, paternal education, study centre
*Similar results for analyses including only non-smoking mothers (data
not shown)
Dose-response relationship with paternal smoking
Maternal smoking had no effect in pooled CLIC analysis or meta-analysis
and is not adjusted for
High correlation between pre-and postnatal paternal smoking. Limited
ability to identify specific windows of exposure
Medium
Milne et al.
(2012), Australia
SR and meta-analysis
10 case control studies,
including own study
Any versus none:10
studies
5338 cases
Controls: NA
>20 CPD:7 studies
2118 cases
Controls: NA
ALL
Paternal smoking around the time of
conception:
Any versus none: OR 1.15 (1.06–1.24)
>20 CPD: OR 1.44 (1.24–1.68)
All studies except own study by Milne et al. (2012) are also included in
the meta-analysis by Liu et al. (2011)
Low
Liu et al. (2011),
USA
SR and meta-analysis,
18 case control studies
Preconception:
13 studies
Cases and controls: NA
ALL
Paternal smoking during preconception:
AOR 1.25 (1.08–1.46)*
Paternal smoking during pregnancy:
AOR 1.24 (1.07–1.43)
Dose-response a. >10 CPD; b. 10–19; c.>20
a. AOR 1.17 (0.9–1.54)
b. AOR 1.25 (1.01–1.55)
c. AOR 1.30 (1.09–1.55)
Primarily interviews by mothers
Age 18 month to 18 years
Most studies matched and adjusted for potential confounders
*Only 5 studies included in MA adjusted for maternal smoking
Also, a positive association between ALL and paternal ever smoking and
at each exposure time period examined
Medium
Original articles n = 19
Brondum et al.
(1999), USA
Case control
(CCG study)
1989–93
1618 ALL
1722 controls
450 AML
523 controls
ALL
Paternal smoking 1 month before pregnancy
AOR 1.07 (0.90–1.27)
Father (not mother) ever smoked (n = 1842)
AOR 1.04 (0.86–1.26)
AML
Paternal smoking 1 month before pregnancy
AOR 0.87 (0.64–1.18)
Father (not mother) ever smoked (n = 517)
AOR 1.32 (0.91–1.93)
Telephone interview with parents mostly mothers
Child age:
ALL <15 years, AML <18 years
Matched by age, race, telephone code area
Adjusted for annual income, father’s and mother’s exposures, race and
education
No association with maternal smoking, parental years of smoking, or
number of pack-years
Medium
Case control 85 cases ALL Face-to-face interview with parents Low
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Table X Continued
Author, year,
country
Study design Number of deliveries
and children
Result Outcomes
Adjustments
Quality
assessmentOutcomes
(Risk estimates)
Castro-Jimenez
and Orozco-
Vargas (2011),
Colombia
2000–2005 85 controls Paternal preconception smoking
AOR 1.93 (1.06–3.54)
Age <15 years
Matched control sex, age, region
Not adjusted for maternal smoking but of no significance
Chang et al.
(2006), USA
Case control
1995–2002
(Northern California
Childhood leukaemia
study)
281 ALL
46 AML
416 controls
Paternal preconception
smoking
ALL:
74 cases
70 controls
AML:
16 cases
8 controls
ALL
Paternal preconception smoking
AOR 1.32 (0.86–2.04)
AML
Paternal preconception smoking
AOR 3.84 (1.04–14.17)
Self-administered questionnaire/in-person interview of mothers
Age <15 years
Matched on age, maternal race, and Hispanic ethnicity.
Adjusting for household income
Maternal smoking was not associated with increased risk of ALL or AML
Data included in Metayer et al. (2013)
Low
Farioli et al.
(2014), Italy
Case control
1998–2003
(SETIL study)
557 cases
855 controls
1–10 CPD:
77 cases
108 controls
>10 CPD:
151 cases
222 controls
ALL
Only paternal smoking
1–10 CPD in conception period
AOR 0.86 (0.58–1.26)
>10 CPD in conception period
AOR 0.74 (0.51–1.05)
Personal interview with parents
Age <10 years
Mutually adjusted models
also including paternal smoking during pregnancy and maternal smoking
in first trimester
Child second-hand-smoking (SHS), birth order, BW, duration of breast
feeding, mat and pat age, educational level, birth year mother, parental
exposure benzene
Low
Ji et al. (1997),
China
Case control
1981–1991
642 cases
642 controls
No maternal smoking
Acute leukaemia
166 case control pairs
Lymphoma
87 case control pairs
Cancer
<2 Pack-years (PY)
2–5 PY
>5 PY prior to conception
Acute leukaemia AOR 2.4 (1.1–5.6)*
ALL AOR 3.8 (1.3–12.3)*
AML AOR 2.3 (0.4–14.8)*
Lymphoma AOR 4.5 (1.2–16.8)*
All cancers AOR 1.7 (1.2–2.5)*
Paternal and maternal interviews by trained interviewers
Age <15 years. Matched for sex, year of birth
Adjusted for BW, income, paternal age, education and alcohol
For <5 PY there were no significant risk in any of the cancers
Low
John et al. (1991),
USA
Case control
1976–83
223 cases
196 controls
Cancer
Paternal smoking preconception period,
absence of maternal smoking
ALL: AOR 1.4 (0.6–3.1)
Lymphomas: AOR 1.6 (0.5–5.4)
Brain cancer: 1.6 (0.7–3.5)
All cancers: AOR 1.2 (0.8–2.1)
Personal interview
Prenatal exposure
Age 0–14 years
Matched for age, sex, area
Absence of maternal smoking:
Adjusted for father’s education.
Low
Lee et al. (2009),
Chorea
Case control
2003–2005
164 cases leukaemia
106 ALL
164 controls
All leukaemia and ALL
PY before pregnancy
All leukaemia: >10 PY: AOR 1.7 (0.9–3.3)
ALL: >10 PY: AOR 1.6 (0.8–3.5)
Interview with mothers (93.5%)
Age 0–18 years
Matched for age and sex.
Adjusted for age, gender, father’s education and birth weight
Maternal smoking was too small (6.1% in controls) to be evaluated in
childhood leukaemia risk and was not considered further
Low
Case control 399 cases Acute leukaemia Personal interviews with each child parents Low
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MacArthur et al.
(2008), Canada
(the cross-Canada
childhood leukaemia
study)
1990–1994
399 controls
109 cases
96 controls
Paternal smoking before pregnancy:
<10 CPD
10–19 CPD
≥20 CPD
All leukaemia:
AOR 0.99 (0.50–1.99)
AOR 1.18 (0.70–1.20)
AOR 1.14 (0.79–1.64)
ALL:
APR 0.87 (0.42–1.81)
AOR 1.21 (0.70–2.08)
AOR 1.15 (0.79–1.67)
AML
AOR 2.98 (0.70–12.75)
AOR 0.93 (0.25–3.45)
AOR 0.90 (0.34–2.38)
Age 0–14 years
Matched for age, gender, area
Conditional logistic regression
Maternal age, mat education, household income, ethnicity, and no of
residences since birth
Not directly adjusted maternal
Smoking, but maternal risk estimates did not change when paternal
smoking patterns were considered
Magnani et al.
(1990)
Case control
1974–1980
1981–1984
142 ALL
22 AnLL
19 (NHL)
307 controls
Leukaemia and lymphoma
Paternal smoking preconception and up to
childbirth:
ALL AOR 0.90 (0.57–1.42)
AnLL AOR 0.9 (0.3–2.1)
Lymphoma AOR 6.7 (1.0–43.4)
Personal Interview
Mean age:
Cases 6.1 (3.6)
Control 6.6 (3.5)
Four residence strata
Adjusted for socio-economic status
Low
Mattioli et al.
(2014), Italy
Case control
(SETIL study)
1998–2003
82 AnLL cases
916 ALL cases
1044 controls
(128 matched to AnLL
and 916 matched to ALL
cases)
Acute non-Lymphatic Leukaemia (AnLL)
Paternal smoking in the conception period
1–10 CPD: AOR 1.34 (0.65–2.76)
≥11 CPD: AOR 1.79 (1.01–3.15)
Personal interview of parents
Age 0–10 years Matched for date of birth, sex, residence
Inverse probability weighting adjusting for sex, provenience, birth order,
BW, breast feeding, parental educational level, age, birth year,
occupational exposure to benzene
Not directly adjusted maternal smoking but no association on AnLL and
maternal smoking during pregnancy
Low
Menegaux et al.
(2007), France
Case control
1995–1998
472 cases
407 ALL
62 AML
3 other
567 controls
Childhood acute leukaemia (ALL and AML)
Paternal smoking 3 months before pregnancy
All acute leukaemia
≤20 CPD: AOR 1.2 (0.9–1.6)
>20CPD: AOR 1.0 (0.6–1.7)
ALL
≤20 CPD: AOR 1.2 (0.9–1.6)
>20 CPD: AOR 1.2 (0.7–2.0)
AML
≤20 CPD: AOR 0.9 (0.5–1.7)
>20 CPD: AOR 0.2 (0.02–1.7)
Standardised self- administered questionnaire to mothers
Age <15 years
Matched for age, gender, region
Adjusted for matched age, gender, region, socio-professional category,
birth order
Not directly adjusted for maternal smoking but not significant
Low
Metayer et al.
(2013), USA
Case control
(NCCLS study)
1996–2008
767 ALL
135 AML
1139 controls
ALL and AML
Paternal prenatal smoking (3 month before
and/or during pregnancy)
ALL: AOR 1.17 (0.91–1.50)*
AML: AOR 1.36 (0.82–2.24)*
Paternal prenatal smoking and child’s passive
smoking
ALL: AOR 0.94 (0.69–1.27)**
AML: AOR 1.14 (0.55–2.39)**
Phase 1: Self-administered questionnaire/
Phase 2: In-person interview of mainly mothers
Age < 15 years
Matched on age, maternal race, and Hispanic ethnicity
Adjusting for matching variables and household income
*Not adjusted for maternal smoking but no significant association with
ALL or AML
**adjusted for maternal prenatal smoking
Expansion of Chang et al. (2006)
Low
Milne et al.
(2012), Australia
Case control
(Aus-ALL study)
2003–2006
388 cases
868 controls
ALL
Paternal smoking during conception year:
Any: AOR 1.22 (0.92–1.61)
1–14 CPD: AOR 1.00 (0.66–1.52)
Self-administered questionnaires
from both parents
Age <15 years
Matched by age, sex, state of residence
Low
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Table X Continued
Author, year,
country
Study design Number of deliveries
and children
Result Outcomes
Adjustments
Quality
assessmentOutcomes
(Risk estimates)
>15 CPD: AOR 1.35 (0.98–1.86) Adjusted for matching variables, paternal age, parental education, ethnicity
Maternal smoking was not associated with ALL and paternal smoking
unchanged when adjusted for maternal smoking (data not shown)
Orsi et al. (2015),
France
Case control (ESTELLE
study)
2010–2011
747 CL
636 ALL
100 AML
1421 controls
All leukaemia (AL), ALL, AML
Paternal preconception smoking:
AL: AOR 1.3 (1.0–1.6)
ALL: AOR 1.2 (0.9–1.6)
AML: AOR 1.6 (1.0–2.8)
Paternal smoking during pregnancy:
AL: AOR 1.3 (1.1–1.6)
ALL: AOR 1.3 (1.0–1.6)
AML: AOR 1.6 (1.0–2.5)
Telephone interview with parents, mostly mothers
Age <15 years
Matched for age, sex
Adjusted for age, sex, mother’s age and education, birth order and
maternal smoking
Low
Pang et al. (2003),
UK
Case control
(UKCCS)
1991–96
3585 case fathers
6987 control fathers
Leukaemia
Paternal preconception smoking
1–19 CPD: AOR 1.12 (0.96–1.32)
20+ CPD: AOR 1.01 (0.87–1.17)
ALL: AOR 1.04 (0.91–1.18)
AML: AOR 1.07 (0.80–1.43)
Personal interview with parents
Age <15 years
Matched for sex, age, region
Adjusted for matching variables, parental age, deprivation score
Medium
Rudant et al.
(2008), France
Case control
(ESCALE study)
2003–4
647 ALL
102 AML
1681 controls
128 HL
848 controls
164 NHL
1312 controls
Hematopoietic malignancies
Paternal smoking from the year prior to the
child’s birth to the interview
ALL: AOR 1.4 (1.1–1.7)
AML: AOR 1.5 (1.0–2.3)
Hodgkin’s lymphoma (HL): AOR 1.2 (0.8–1.7)
Non-Hodgkin’s lymphoma (NHL): AOR 1.6
(1.1–2.3)
<10 CPD:
ALL: AOR 1.2 (0.8–1.6)
AML: AOR 1.4 (0.7–2.9)
HL: AOR 1.4 (0.7–2.6)
NHL: AOR 1.5 (0.8–2.6)
10–19 CPD:
ALL: AOR 1.2 (0.9–1.6)
AML: AOR 1.3(0.7–2.4)
HL: AOR 0.8 (0.4–1.6)
NHL: AOR 1.7 (1.1–2.7)
20+ CPD:
ALL: AOR 1.7 (1.3–2.1)*
AML: AOR 1.7(1.0–2.9)**
HL: AOR 1.2 (0.7–2.0)
NHL: AOR 1.7 (1.1–2.6)***
Telephone interview of mothers
Age <15 years
Matched for age, gender
Adjusted for age. Gender, parental professional category, maternal age
at the time of birth
Maternal smoking was not associated with significant increased risk
Trend analyses:
*P < 0.0001
**P < 0.045
***P < 0.01
Low
Schuz et al.
(1999), Germany
Case control
(NW and NI study)
2354 cases
2588 controls
Acute leukaemia and NHL
Paternal smoking before pregnancy
Questionnaire followed by telephone interview by parents
Age <15years
Medium
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NW: 1992–97
NI: 1980–94
955 Acute leukaemia
955 controls
221 NHL
2540 controls
Acute leukaemia (ALL and AnLL)
1–10 CPD AOR 1.1 (0.8–1.5)
11–20 CPD AOR 1.0 (0.8–1.2)
>20 CPD AOR 0.9 (0.7–1.2)
NHL
1–10 CPD AOR 1.6 (1.0–2.5)
11–20 CPD AOR 1.1(0.7–1.6)
>20 CPD AOR 1.1 (0.7–1.8)
Matched for gender, age, region
Adjusted for socio-economic status
Not adjusted for maternal smoking, but no association with maternal
smoking
Study also includes estimates on CNS tumours, neuroblastoma,
nephroblastoma, bone tumour, soft tissue sarcoma and no associations
was found
Shu et al. (1996),
USA
Case control
1983–88
(CCG study)
302 cases
203 ALL
88 AML
11 other leukaemia
558 controls
Paternal smoking:
191 ALL
79 AML
ALL and AML
Only paternal smoking 1 month prior to
pregnancy (A) and
during pregnancy (B)
A:
ALL: AOR 1.56 (1.03–2.36)
1–10 CPD AOR 2.40 (1.00–5.72)
11–20 CPD AOR 1.33 (0.79–2.34)
>20 CPD AOR 1.51 (0.82–2.77)
AML: AOR 0.75 (0.35–1.62)
1–10 CPD AOR 0.42 (0.09–1.95)
11–20 CPD AOR 0.73 (0.27–1.94)
>20 CPD AOR 1.29 (0.44–3.74)
B:
ALL: AOR 1.45 (0.95–2.19)
AML: AOR 0.82 (0.38–1.78)
Telephone interview with mothers and fathers (71%)
Age ≤18 months
Matched by age, region.
Adjusted for sex, paternal age, education, maternal alcohol consumption
during pregnancy
Maternal smoking 1 month prior to pregnancy and during pregnancy
was not associated with increased risk of ALL or AML
Low
Sorahan et al.
(2001), UK
Case control
(OSCC study)
1980–83
555 cases
555 controls (GP)
Cases/controls:
7/9
18/16
36/35
9/5
12/3
ALL
Paternal smoking before the pregnancy
<10 CPD:
GP: 0.99 (0.35–2.85)
10–19 CPD
GP:1.34 (0.62–2.91)
20–29 CPD
GP: 1.32 (0.72–2.45)
30–39 CPD
GP: 2.33 (0.71–7.63)
40+ CPD
GP: 5.29 (1.31–21.30)
P for trend P = 0.06
Interview of parents
Child age <15 years
Matched on region, sex, date of birth
Adjusted for maternal age, paternal age, SES, ethnicity
Low
Other cancers n = 19
Barrington-Trimis
et al. (2013), USA
Case control
1984–1991
202 cases
286 controls
Only paternal smoking:
25 cases
27 controls
Brain tumours
Only paternal smoking during pregnancy
AOR 1.24 (0.66–2.35)
In-person maternal interview
Age ≤10 years
Matched by age, sex, study centre
Adjusted for race, sex, age at diagnosis, maternal education, birth year,
centre
Low
Bunin et al.
(1994), USA
Case control
1986–1989
155 AP
166 PNET
321 Controls
64/63
60/58
86/82
85/88
Astrocytic gliomas (AG)
Primitive neuroectodermal tumours (PNET)
Paternal smoking during pregnancy
AG: AOR 1.0 (0.6–1.7)
PNET: AOR 1.0 (0.6–1.7)
Paternal smoking ever
AG: AOR 1.1 (0.7–18.0)
PNET: AOR 0.9 (0.6–1.5)
Trained interviewers with parents
Child age <6 years
Matched on race, year of birth, telephone area code and prefix
AG: Adj. income level
PNET: No adjustment
Low
SEARCH program 1218 cases Brain tumours Nine centres in 7 countries Medium
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Table X Continued
Author, year,
country
Study design Number of deliveries
and children
Result Outcomes
Adjustments
Quality
assessmentOutcomes
(Risk estimates)
Filippini et al.
(2002), Italy
1980–1992 2223 controls
633/1190
AOR 1.1 (0.9–1.2) In-person interview of mostly mothers
Child age 0–19 years
Post hoc strata matched on age, sex and centre
Adjusted for matched variables and maternal level of education
Gold et al. (1993),
USA
Case control
1977–81
361 cases
1083 controls
Only paternal smoking:
81 cases
247 controls
Brain tumours
Only paternal smoking during year index child
was born:
AOR 0.94 (0.66–1.33)
Structured interview from each parent
Age <18 years
Matched for age, sex, maternal race
Cases represent 85% of cases identified by the registries
Medium
Hu et al. (2000),
China
Case control
1991–1996
82 cases
246 controls
Paternal smoking + no
maternal smoking:
44 cases
124 controls
Brain tumours
Smoking PY
AOR 1.16 (0.65–2.08)
During hospitalization, paternal and maternal interviews by trained
interviewers
Age <19 years
Matched for sex, age, area of residence
Adjusted for maternal education, family income
Low
Ji et al. (1997),
China
Case control
1981–1991
1981–91
642 cases
642 controls
Brain tumours
107 pairs
Acute leukaemia,
166 pairs
Lymphoma
87 pairs
Brain tumours
Paternal smoking before conception
<2 PY
All cancers: AOR 1.2 (0-8-1.8)
Brain tumours: AOR 1.5 (0.5–4.4)
2–5 PY
All cancers: AOR 1.3 (0.9–2.0)
Brain tumours: AOR 1.7 (0.5–5.8)
>5 PY prior to conception
All cancers: AOR 1.7 (1.2–2.5)
Brain tumours: AOR 2.7 (0.8–9.9)
Paternal and maternal interviews by trained interviewers
Age <15 years
Matched for sex, year of birth
Adjusted for BW, income, paternal age, education and alcohol
Low
John et al. (1991),
USA
Case control
1976–83
1976–1983
223 cases
196 controls
60 exposed cancers
45 exposed controls
Brain tumours
Paternal smoking in preconception period in
the absence of maternal smoking
Brain tumours: AOR 1.6 (0.7–3.5)
All cancers: AOR 1.2 (0.8–2.1)
Personal interview
Prenatal exposure
Matched for age, sex, area
Absence of maternal smoking:
Adjusted for father’s education
Low
Johnson et al.
(2013)USA
Case control
2000–2008 (Cases)
1994–2008 (controls)
383 cases
387 controls
A: Paternal smoking
within the year before
pregnancy:
115 cases, 84 controls
B: Paternal smoking
during pregnancy
95 cases, 69 controls
Hepatoblastoma
Paternal smoking the year before pregnancy
A: AOR 1.4 (1.0–2.0)
B: AOR 1.4 (0.9–2.0)
Maternal telephone interviews
Age <6 years
Matched for BW, gender, birth year and region
Adjusted for BW, year of birth, sex, maternal race and education
Not directly adjusted for maternal smoking had no influence and
therefore not adjusted for
Medium
McCredie et al.
(1994), Italy +
Australia
Case control
Population-based
1985–1989
82 cases
164 controls
Ever smoking
23 cases, 28controls
During pregnancy
41cases, 49controls
Malignant brain tumours
Paternal smoking ever (at least 3 months at
any time before pregnancy)
AOR 2.0 (1.0–4.1)*
Paternal smoking during pregnancy
AOR 2.2 (1.2–3.8)
Structured at home interviews with mothers
Child age up to 14 years
Matched on sex and age
*Ever smoked is adjusted for fathers schooling
Low
Case control 302 cases Brain tumours Questionnaire to parents Medium
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Milne et al.
(2013), Australia
(Aus-CBT study)
2005–2010
941 controls
Preconception:
74 cases
222 controls
During pregnancy
71 cases
202 controls
Paternal smoking preconception
AOR 0.99 (0.71–1.38)
1–14 CPD: AOR 1.31 (0.82–2.11)
15+ CPD: AOR 0.83 (0.55–1.24)
Paternal smoking during pregnancy*
AOR 1.04 (0.74–1.46)
1–14 CPD: AOR 1.30 (0.79–2.13)
15+ CPD: AOR 0.92 (0.61–1.38)
Age <15 years
Matched for age, sex, state of residence
Adjusted for matching variables, ethnicity, year of birth group, parental
age, household income
*Results shown are not adjusted for maternal smoking, but no
association was found with maternal smoking
Similar results when analysis was restricted to children whose other
parent did not smoke (data not shown)
Norman et al.
(1996), USA
Case control
Population-based
1984–1991
540 cases
801 controls
Ever smoked:
262 cases, 380 controls
During pregnancy:
174 cases, 238 controls
Childhood brain tumours
Ever smoked AOR 1.1 (0.84–1.3)
Paternal smoking during pregnancy and no
maternal smoking
AOR 1.2 (0.95–1.6)
In-person or telephone interviews of mothers and fathers (77%)
Child age <20 years
Matched on birth year, sex, age at diagnosis
Adj. matching criteria + maternal race/ethnicity
Medium
Pang et al. (2003),
UK
Case control
(UKCCS)
1991–1996
3585 case fathers
6987 control fathers
Paternal preconception
smoking
All cancers
583 cases, 1003 controls
757 cases, 1440 controls
CNS tumours
101 cases, 1003 controls
138 cases, 1440 controls
Cancer
Paternal smoking during the year before birth
All cancers
1–19 CPD: AOR 1.11 (0.98–1.25)
20+ CPD: AOR 1.01 (0.90–1.12)
CNS tumours
1–19 CPD: AOR 1.08 (0.85–1.38)
20+ CPD: AOR 1.03 (0.82–1.28)
Personal interview with parents
Age <15 years
Matched for sex, age, region
Adjusted for matching variables, parental age, deprivation score
Medium
Plichart et al.
(2008), France
Case control
(ESCALE study)
2003–2004
209 cases
1681 controls
Paternal smoking + non-
smoking mother
74 cases, 516 controls
CNS tumours
Only paternal smoking in the year prior the
child’s birth
AOR 1.3 (1.0–1.9)
Maternal telephone interview
Age <15 years
Matched for age, sex and number of children <15 years of age in the
household
Adjusted for age, gender
No association between maternal smoking during pregnancy and CNS
tumours.
Low
Sorahan et al.
(1997a), UK
Case control
(OSCC study)
1953–1955
1549 cases
1549 controls
655 cases, 618 controls
Death of childhood cancer
Paternal smoking at death of child, father only
ARR 1.30 (1.10–1.53)
Interview parents, usually mothers (response rate 88%)
Matched for sex, date of birth and region
Adjusted for social class, parental age at birth, sib-ship position,
obstetric radiography
Medium
Sorahan et al.
(1997b), UK
Case control
(OSCC study)
1971–1976
2587 cases
2587 controls
630 cases
573 controls
Death of childhood cancer
Paternal smoking at death of child, father only
14% of the cancers could be related to
paternal smoking
(all cancer and onset at all ages)
ARR 1.29 (1.10–1.51)
Interview of parents, usually mothers
Child age <16 years
Matched for sex, date of birth, region
Adjusted for social class, parental age at birth, sib-ship position,
obstetric radiography
Medium
Sorahan et al.
(2001), UK
Case control
(OSCC study)
1980–83
555 cases
555 controls (hospital)
555 controls (GP)
Cases/GP/Hospital
26/34/27
79/60/70
114/122/121
23/32/48
Childhood cancer
Paternal smoking before the pregnancy
ARR:
<10 CPD:
GP: 0.94 (0.53–1.66); Hospital: 0.92
(0.51–1.65)
10–19 CPD
Interview of parents
Child age <15 years
Matched on region, sex, date of birth
Adjusted for maternal age, paternal age, SES, ethnicity
Low
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Table X Continued
Author, year,
country
Study design Number of deliveries
and children
Result Outcomes
Adjustments
Quality
assessmentOutcomes
(Risk estimates)
28/21/40 GP: 1.63 (1.10–2.41); Hospital: 1.06
(0.72–1.56)
20–29 CPD
GP: 1.46 (1.05–2.03); Hospital: 1.11
(0.80–1.53)
30–39 CPD
GP: 0.95 (0.52–1.73); Hospital: 0.45
(0.26–0.77)
40+ CPD
GP: 1.77 (0.94–3.34); Hospital: 0.66
(0.39–1.11)
P for trend
GP P = 0.02; Hospital P = 0.16
CNS tumours also stratified on CPD, but no
total ARR
P for trend 0.67
Data adjusted for maternal smoking is not
shown but
with a significant positive trend (P = 0.03)
between cancer
and paternal smoking compared to GP
controls
Sorahan and
Lancashire (2004),
UK
Case control
(OSCC study)
Deaths 1953–55
1971–76
1977–81
5777 case control
matched pairs
Paternal smoking only:
All cancers
1637 cases
1545 controls
Hepatoblastoma
43 cases
8 cases
1545 controls
Death of childhood cancer and
hepatoblastoma
All cancers
ARR 1.28 (1.15–1.42)
Hepatoblastoma
ARR 1.23 (0.46–3.28)
Interview parents, usually mother
Child age <16 years
Matched for sex, age at death, year of death
Adjusted for sex, age at death, year of death, social class, sib-ship
position, maternal age, paternal age, obstetric radiography
Medium (all
cancers)
Low
(hepatoblastoma)
Schuz et al.
(1999), Germany
Case control
(NW and NI study)
NW:1992–97
NI:1980–94
NW:1992–97
NI:1980–94
2358 cases
2588 controls
385 CNS tumours
155 neuroblastomas
2540 nephroblastomas
95 bone tumours
133 soft tissue sarcomas
CNS tumour, Neuroblastoma,
Nephroblastoma, Bone tumour, Soft tissue
sarcoma
Paternal smoking before pregnancy
1-10 CPD:
CNS tumour: AOR 0.8 (0.5–1.2)
Neuroblastoma: AOR 0.6 (0.3–1.1)
Nephroblastoma: AOR 0.8 (0.4–1.4)
Bone tumour: AOR 0.5 (0.2–1.2)
Soft tissue sarcoma: AOR 0.8 (0.4–1.6)
11–20 CPD:
CNS tumour: AOR 1.1 (0.8–1.4)
Neuroblastoma: AOR 1.1 (0.7–1.6)
Questionnaire followed by telephone interview by parents
Age <15years
Matched for gender, age, region
Adjusted for socio-economic status
Not adjusted for maternal smoking, but no association with maternal
smoking.
Study also includes estimates on
Acute leukaemia and NHL
Low
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Nephroblastoma: AOR 0.8 (0.5–1.3)
Bone tumour: AOR 0.8 (0.4–1.3)
Soft tissue sarcoma: AOR 1.2 (0.8–1.8)
>20CPD
CNS tumour: AOR 1.0 (0.7–1.4)
Neuroblastoma: AOR 1.2 (0.7–2.1)
Nephroblastoma: AOR 0.9 (0.5–1.6)
Bone tumour: AOR 0.9 (0.4–1.8)
Soft tissue sarcoma: AOR 0.9 (0.4–1.6)
Yang et al. (2000),
USA & Canada
Case control
(CCG and POG
studies)
1992–94
504 cases
504 controls
Preconception
137 cases, 122 controls
Neuroblastoma
Paternal smoking one month before
conception
AOR 1.2 (0.8–1.6)
Telephone interview with parents
Child age <19 years
Matched for date of birth
Adjusted for gender, mother’s race, father’s education, household
income in birth year
Not directly adjusted maternal smoking, but no association with risk of
neuroblastoma
Medium
Cardio-metabolic outcomes (n = 9)
Brion et al.
(2007), UK
Cohort study
Avon longitudinal study
6396 children (Model 1)
3736 children (Model 5)
Blood pressure at 7 years
Systolic blood pressure:
Model 1: Beta 0.44 (−0.07–0.95) P = 0.09
Model 5: Beta 0.17 (−0.52–0.86) P = 0.6
Diastolic blood pressure:
Model 1: Beta 0.10 (−0.26–0.47) P = 0.6
Model 5: Beta −0.25 (−0.72–0.22) P = 0.3
Questionnaires sent to partners at 18 weeks gestation on if they had
smoked regularly in the last 9 months
Model 1: Child age, sex
Model 5: Additionally, adjusted for maternal/partner factors, social
factors, breast feeding
Medium
de Jonge et al.
(2013), US
Nurse’s Health Study II
and Nurses’ Mothers’
cohort
1989–2007
5777 non-smoking
mothers
3078 paternal smoking
2699 no paternal smoking
Hypertension in daughters in adulthood
(self-reported physician diagnosed)
Paternal smoking during pregnancy
Maternal age: ARR 1.12 (1.06–1.18) +
perinatal variables: ARR 1.09 (1.03–1.15) +
BW: ARR 1.08 (1.03–1.14) +
adult life variables: ARR 1.08 (1.02–1.14) +
body shape and
weight until age: ARR 18:1.07 (1.01–1.13) +
current BMI: 1.04 (0.99–1.10)
Self-administered questionnaires to nurse’s mothers 2001
Cox proportion hazard models
Multiple adj. and additional adj. for perinatal variables, adult life
variables, body shape and weight until age 18 years, current BMI
Medium
Durmus et al.
(2011), The
Netherlands
Prospective cohort
study
2002–2006
4028 non-Smoking
mothers
Paternal smoking during
pregnancy:
1397 fathers
0–4 CPD: 607 fathers
≥5 CPD: 753 fathers
2572 no paternal smoking
BMI at 3, 6, 12, 24, 36, 48 months
Paternal smoking during pregnancy and
difference in BMI at 12 months:
Standardized coefficients (95% CI):
0.06 (−0.01, 0.13)
0–4 CPD
0.04 (−0.05, 0.13)
≥5 CPD
0.08 (−0.01, 0.17)
P for trend P = 0.01
Similar no difference in BMI at 3, 6, 24, 36 and
48 months and no trend
Postal questionnaires to mothers
Linear mixed models
Adj. Child’s age at visit, sex, paternal ethnicity and education, paternal
height and weight and breast feeding (yes/no)
Reporting bias
Similar information completed by the fathers in 3358 participants – good
agreement between mat and pat assessment
Medium
Florath et al.
(2014), Germany
Prospective cohort
Born 2000–2001
609 healthy mature
newborns
BMI at child age 8 years
Smoking during pregnancy
BMI at 8 years
During hospitalization after delivery standardized maternal interviews by
trained interviewers. Follow-up to age 8 years
Linear regression
Medium
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Table X Continued
Author, year,
country
Study design Number of deliveries
and children
Result Outcomes
Adjustments
Quality
assessmentOutcomes
(Risk estimates)
Paternal smoking during
pregnancy in non-
smoking mothers
157 paternal smoking
401 no paternal smoking
Adjusted regression coefficient: 0.34
(0.01–0.66)
Adjusted for paternal BMI and education, maternal pre-pregnancy BMI,
BW, monthly weight gain, exclusive breast feeding, body height, TV
consumption, sports activities, diet score at 8 years and age at
anthropometric measurements.
Conclusion:
Residual confounding conditions in smoking families by living rather than
specific intrauterine exposure may account for the increased risk of
offspring overweight
Howe et al.
(2012), UK
Cohort study
Avon longitudinal study
Height:
4832 children
PI: 4777 children
BMI: 4534 children
Growth 29–120 months
Girls: 0.0012 (0.0021), P = 0.01
Boys: −0.0012 (0.0020), P = 0.8
Ponderal index 2–24 months:
Girls: 0.0043 (0.0078), P = 0.35
Boys: −0.0011 (0.0069), P = 0.73
BMI 103–120 months:
Girls: 0.0042 (0.0036), P = 0.54
Boys: 0.0033 (0.0021), P = 0.77
Self-reported data
Height 0–10 years
Ponderal index 0–2 years
BMI 2–10 years
Maternal education, household social class, parity, maternal age,
maternal height, maternal BMI, gestational age, breast feeding
Medium
Kwok et al.
(2010), Hong
Kong
Birth Cohort study
1997
Non-smoking mothers:
7924 children
6710 children with BMI at
7 years
6519 children with BMI at
11 years of age
BMI and height at child age 7 and 11 years
Daily prenatal and early postnatal paternal
smoking:
BMI, Z-score difference, mean (95%CI)
Child age 7 years: 0.10 (0.02–0.19)
Child age 11 years: 0.16 (0.07–0.26)
No difference in height Z scores
Standardized self- administered questionnaire at maternal and child-
health centres
Daily prenatal and early postnatal paternal smoking in non-smoking
women
Adjusted for gender, birth order, highest parental education, mother’s
place of birth, pubertal status (for 11 years) highest parental occupation,
household income per person, breast feeding history, number of
hospital admissions attributable to infections at 0 to 6 months
Medium
Leary et al.
(2006), UK
Cohort study
Avon longitudinal study
Examination at 9 years
6470 children
5615 children*
3649 children**
BMI, total fat, truncal fat, total lean (DXA
scanner) at mean child age 9.9 years
Paternal smoking during pregnancy
*BMI: beta 0.11 (0.05, 0.17) < 0.001
*Total fat: beta 0.08 (0.03–0.13) P = 0.001
Questionnaires to mothers
Adjusted for maternal smoking
*Sex, child age at DXA-scan, **Additionally adjusted for maternal,
partner, social and infant feeding factors
Medium
Taal et al. (2013),
The Netherlands
Prospective cohort
study
2008–2012
Non-smoking mothers
during singleton
pregnancy
4070 cases
Fathers smoking 1298
cases
Fathers non-smoking
2369 controls
Stroke, volume, cardiac output, larger AOD
(aortic root diameter), fractional shortening at
child age 6 years
Regression coefficients
Mean Systolic blood pressure (mmHg)
−0.18 (−0.69–0.33) test for trend over
smoking cat. 0.741
Mean diastolic blood pressure (mmHg)
0.12 (−0.39–0.52) test for trend over smoking
cat. 0.702
Aortic root diameter (mm)
Difference 0.17 (0.05–0.28)
Questionnaires in second and third trimester
Mixed models and multiple linear regression models
Adjusted for maternal age, parity, mixed educational level, pre-
pregnancy BMI, BP at intake, sex, GA, BW, breast feeding status,
current age and BMI
Medium
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Toschke et al.
(2007), UK
Cohort study
NCDS: 1958
BCS70:1970
Two birth cohorts
Total: 11 282 children
NCDS:
5214 children
BCS70:
6068 children
Diabetes Mellitus Type 1
Paternal smoking
OR 0.48 (0.29–0.80)
Combined OR:
AOR 0.44 (0.25–0.75)
NCDS:
AOR 0.37 (0.18–0.75)
BCS70:
AOR 0.54 (0.24–1.27)
Interview of mothers
NCDS: Up 16 years
BCS70:5 and 10 years
Adjusted for maternal smoking, sex, maternal age, paternal age, number
of sibling, social class, cohort (NCDS, BCS70)
Medium
Neuro-developmental n = 6
Brion et al.
(2010), UK
Birth cohorts
Avon Longitudinal
study of Parents and
Children (ALSPAC),
UK
1991–1992
Pelotas, Brazil
1993
ALSPAC:
6735 children
Strength and difficulties
questionnaire (SDQ) to
parents
Pelotas:
509 children
Child Behaviour Checklist
(CLBL) followed up by a
psychologist
Psychological problems
Paternal smoking during pregnancy
Hyperactivity/attention problem**
ALSPAC AOR 1.03 (0.91–1.17)
Pelotas AOR 1.04 (0.71–1.50)
Emotional/Internalizing problem**
ALSPAC AOR 0.93 (0.82–1.06)
Pelotas AOR 0.85 (0.58–1.24)
Conduct/Externalizing problems**
ALSPAC AOR 1.11 (0.98–1.26)
Pelotas AOR 0.96 (0.66–1.41)
Peer/social problems**
ALSPAC AOR 1.01 (0.89–1.15)
Pelotas AOR 0.98 (0.67–1.45)
4-years of age,
Smoking information at perinatal visit
Adjusted in 5 levels for:
Unadjusted
Maternal and paternal education, income, social class
Mediators
Parental psychological
**Mutually adj. model incl. maternal and paternal smoking with
adjustment for one another
Medium (ALSPAC)
Low (Pelotas)
Langley et al.
(2012), UK
Longitudinal cohort
study
Pregnant women
1991–2000
Fathers only smoking
6478 children
ADHD diagnosis
5719 children
ADHD
Paternal smoking during pregnancy
0, 1–9, 10–19, >=20 cig per day
Paternal smoking and mother non-smoking
Adjusted beta=0.12 (0.04–0.20)
AOR 1.42 (1.04–1.93)
Self-reported questionnaire
(mother)
Child age 7–8 years
Linear regression
F-statistics
Adjusted for sex, ethnicity, multiple pregnancy, maternal alcohol during,
education, pregnancy, parental social class, maternal education
Medium
Nomura et al.
(2010), USA
Cohort study 209 children
Fathers only smoking 40
ADHD
AOR 0.31 (0.06–1.92)
ODD
Not estimable
ADHD and ODD
AOR 0.85 (0.13–5.55)
Interview of parents
Age 3–4 years
Adjusted for gender, age, race and BW of the child, maternal drinking
during pregnancy, family SES, mother’s ADHD symptoms, father’s
ADHD symptoms, mother and father’s smoking history
Low
Tang (2006),
Hong Kong
Case control
2003–2004
392 children newly
diagnosed with
developmental delay
393 controls
Developmental delay
Prenatal paternal smoking
AOR 1.18 (0.86–1.63)
≤5 CPD
AOR 1.15 (0.74–1.77)
>5 CPD
AOR 1.39 (0.75–2.58)
Self-administered questionnaire parents mostly mothers
Age 2–3 years
Matched for age and region
Adjusted for environmental tobacco smoke (ETS) due to other
household smoking other than paternal smoking, child sex, BW, breast
feeding history, housing type, parents educational level and occupation
Medium
Tiesler et al.
(2011), Germany
Cohort study
Delivery 1997–1999
3097 children
1654 ETS at 10 years
40 paternal smoking or
ETS only
Behavioural problems
Prenatal paternal smoking and environmental
tobacco smoking (persons other than mothers
smoking at home, ETS)
Total difficult score (5/40)
APOR 1.21 (0.45–3.27)
Hyperactivity/inattention (8/40)
APOR 2.03 (0.86–4.81)
Self-administered questionnaires
mothers
10 years follow-up
Adjusted for sex, study centre, parental education, maternal age at
birth, time in front of screen, single mother/father
Low
Continued
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The systematic literature search revealed a huge number of articles
which were scrutinized, and 238 of these publications were selected
for inclusion. Although the quality of included articles varied, several
large cohort studies of high quality were identified.
A majority of the included publications investigated the effect of
paternal age on the health of children. A previous systematic review
concerning the effect of paternal factors on obstetric outcomes found
that extremes in paternal age were associated with an increase in LBW,
and there was also an association between paternal height and BW of
offspring (Shah, 2010). Another recent report summarized the associ-
ation between paternal age and health of offspring in a narrative way
(Nybo Andersen and Urhoj, 2017). They reported a strong association
between paternal age and some specific congenital syndromes, namely
cleft palate, acute lymphatic leukaemia, ASD and schizophrenia.
While no clear definition seems to exist for advanced paternal age,
many studies have used 40 years and above as an age limit. A com-
mon problem for many studies of paternal factors, particularly pater-
nal age, is the strong and well-known confounding factor, namely the
effect of maternal age on obstetric and child outcome. A similar influ-
ence is true for other exposures, such as smoking and BMI. In our
meta-analyses we therefore only included publications which had
adjusted for maternal age or smoking, or where it was clear that the
reference group was young mothers or non-smoking mothers,
respectively. We also included some studies in which univariate ana-
lysis of maternal smoking was insignificant, and thus did not adjust for
maternal smoking in the multivariate analyses.
Paternal age
Among obstetric outcomes, we found a small but significantly
increased risk of stillbirth associated with paternal age. We also found
significantly higher risks of birth defects, and specifically of orofacial
clefts and trisomy 21. For other obstetric outcomes and selected
birth defects we could not identify any increased risks. For gastroschi-
sis, there seems to be evidence of an increased risk associated with
younger fathers (Kazaura et al., 2004a, Archer et al., 2007, Yang
et al., 2007, Materna-Kiryluk et al., 2009). The mechanism behind
such an association is suggested to be of socio-economic origin, with
certain life-style factors more common among young fathers (drugs,
smoking, etc) while the increase in risk associated with higher pater-
nal age is possibly of genetic origin, depending on a higher frequency
of de novo mutation in sperm of older fathers.
Children born to older fathers have been reported as having a
higher risk of various cancer types (Sartorius and Nieschlag, 2010). A
meta-analysis (Sergentanis et al., 2015) reported an increased risk of
childhood leukaemia associated with higher parental ages. For the
risk of ALL, they reported an association with both increased mater-
nal and paternal age. In our meta-analysis we did not find an associ-
ation between ALL and advanced paternal age. A possible
explanation for our result could be that we only included studies that
adjusted for maternal age. For other cancer types, it was not possible
to carry out meta-analysis, either because the studies were too few,
of too low quality, or did not adjust for maternal age.
Psychiatric disorders and diseases like autism/ASD (Hultman et al.,
2011; Wu et al., 2017) and schizophrenia (Miller et al., 2010) have
been associated with advanced paternal age. From earlier studies, the
risk seems to increase linearly without any particular threshold. This
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link with advanced paternal age has been found in studies from differ-
ent countries although the magnitude of the associations varies.
ASD is a chronic disease and includes different conditions such as
infantile autism, Asperger’s syndrome, atypical autism and pervasive
development disorder. There are different theories explaining the
aetiology. The genetics of ASD seem complex and may involve gen-
etic, epigenetic and environmental factors (Waye and Cheng, 2017).
The mean number of de novo mutations in human spermatozoa has
been found to increase by around two per year (Kong et al., 2012).
This increased frequency of de novo mutations of older men may
result in both gain and loss of DNA region copy numbers, and may
explain some of the effects associated with increased paternal age.
Other explanations for the paternal effects may include the fact that
these men are more often in the higher or lower socio-economic
groups, they are more likely to be overweight and obese, and they
are more likely to smoke and have a higher alcohol intake.
Furthermore, these men more often suffer from diverse physical and
mental health problems (Nilsen et al., 2013).
In our meta-analysis of autism, 16 studies were included and a
higher risk of autism/ASD was associated with increasing paternal
age (pooled estimate 1.25, 95% CI 1.20–1.30). All studies adjusted
for maternal age. This finding is in line with previous meta-analyses
(Hultman et al., 2011; Wu et al., 2017).
Our meta-analysis of schizophrenia included 11 original articles, all of
these studies adjusted for maternal age. A higher risk of schizophrenia
was observed in the children of older men (pooled estimate 1.31, 95%
CI 1.24–1.38). The previous meta-analysis by Miller et al. (2010) found
a higher level of risk in the oldest fathers (≥50 years), of AOR 1.66
(95% CI 1.46–1.89). Similarly, the meta-analyses by Torrey et al. (2009)
and Wohl and Gorwood (2007) found a strong association between
advanced paternal age and an increased risk of schizophrenia in off-
spring. Limitations in some of the studies include few outcomes of inter-
est, and poorly defined classification of diagnosis. Another limitation is
that it is not possible to adjust for genetic and environmental factors
that could be important confounders in the association between
advanced paternal age and adverse outcomes in offspring. Furthermore,
there is a heterogeneity of different age categories that complicates
comparison between studies. Our results are in line with previous stud-
ies and indicate an association between advanced paternal age and
increased risk of autism, schizophrenia and other psychiatric diseases.
NOTE: Weights are from random effects analysis
.
Overall  (I-squared = 0.0%, p = 0.698)
John (1991)
Filippini (2002)
Subtotal  (I-squared = 0.0%, p = 0.698)
.
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Figure 19 Forest plot describing the association between paternal smoking and risk for brain tumours in the offspring.
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Paternal, BMI, height and/or weight. There are only limited data on
the impact of paternal obesity at the time of conception on short and
long-term health outcomes for children. Information on the father´s
weight and BMI was often documented after the birth of the child,
and those studies were excluded from the analysis. Paternal obesity
has been connected to infertility, a reduced rate of live birth per cycle
in ART, and increased risk of pregnancy non-viability (Campbell et al.,
2015). Obese men have an increased amount of sperm with low
mitochondrial membrane potential, DNA fragmentation, and abnor-
mal morphology, all of which may have harmful effects on fertility
(Campbell et al., 2015). However, if the pregnancy starts, pre-
pregnancy paternal BMI does not seem to exert any independent
effect on the risk of PTB or SGA (Mutsaerts et al., 2014). Actually,
with regard to short-term outcomes, only the height of the father
correlated significantly with the BW of the offspring. On the other
hand, paternal anthropometrics at the time of the child’s birth were
associated with childhood BMI, weight and/or fat mass. However,
paternal height and weight were usually either self-reported, or
reported by the mother, and not measured, which increases the risk
of bias. The majority of studies reported a stronger effect of maternal
BMI than paternal BMI. In one study, Patro and co-workers systemat-
ically evaluated the associations of offspring BMI, or adiposity, with
pre-pregnancy BMI (or adiposity) of the mother and the father (Patro
et al., 2013). They hypothesized that the intrauterine environment is
an independent factor in obesity development, and thus the maternal
effect is likely to be stronger (‘foetal overnutrition hypothesis’), but
found only limited evidence to support the hypothesis.
Paternal smoking. Our meta-analyses on short-term outcomes demon-
strated a small but significant increased risk of SGA if fathers smoked,
but non-significant increased risks of PTB and LBW. While the effect of
maternal smoking on obstetric outcomes is evident, the effect of pater-
nal smoking on obstetric outcomes is still equivocal. Paternal smoking
significantly increased CHD and orofacial clefts, with pooled estimates
of 1.75 and 1.50 respectively. The occurrence of CHD and orofacial
clefts is a result of the interaction of genetic and environmental risk fac-
tors and cigarette smoke comprises numerous chemical carcinogens.
These chemicals have a teratogenic effect on oocytes and sperm DNA
or interfere with foetal cardiac development and other foetal struc-
tures (Deng et al., 2013; Figueiredo et al., 2015). The existing literature
is not able to clarify if the increased risk of CHD associated with pater-
nal smoking is due to a direct effect on sperm, or the result of passive
smoking on oocytes or the foetus: an effect of the latter should be
weaker than that of maternal smoking. The effect of maternal smoking
on orofacial cleft risk is relatively well demonstrated, but an effect on
cardiovascular defects is more dubious or perhaps restricted to only
some forms. Thus, the effect of paternal smoking on orofacial clefts
may be due to maternal passive smoking, and why the effect on CHD
is more likely to be due to paternal smoking per se. Our meta-analysis
of data on brain tumours showed a small but significant increased risk
of brain tumours if fathers smoked, with pooled estimate of 1.12. The
previous meta-analyses on data on leukaemia demonstrated an associ-
ation between paternal smoking at pregnancy for AML (AOR
1.19–1.28) and for ALL (1.15–1.25) (Liu et al., 2011; Milne et al., 2012;
Metayer et al., 2016). Tobacco smoke is known to be leukomogenic,
to introduce oxidative damage in sperm cells resulting in DNA frag-
mentation, and it may also cause persistent changes in miRNA (Liu
et al., 2011; Milne et al., 2012).
The association between paternal smoking and childhood cancer
could hardly be due to maternal passive smoking as maternal smoking
is not with certainty associated with childhood cancer. However, if the
infant or young child has been exposed for passive smoking that may
explain the increased cancer risk, if passive smoking has a carcinogenic
effect. Most of the studies on the effects of exposure to paternal smok-
ing during pregnancy had matched control groups, and risk estimates
were adjusted for relevant confounding factors. Nevertheless, none of
the studies were assessed as being of high quality. Most studies were
retrospective case control studies with a limited number of cases and
controls, where fathers but not mothers smoked.
In the majority of studies, the information on paternal smoking was
gained from interviews with, or questionnaires from, the mothers,
thus introducing recall and selection bias. Obviously, recall bias is of
most concern in long-term outcomes where information on paternal
smoking is obtained several years after childbirth. The extent of under
reporting of paternal smoking is unknown, which may introduce some
non-differential misclassification bias. Furthermore, the dissemination
of information on the adverse consequences of smoking in pregnancy
may have discouraged some parents from disclosing it. Even in some
studies of short-term outcomes, information on BW and gestational
age came in the form of maternal self-reported data rather than hos-
pital files or national registries, meaning that accuracy is less certain.
Most studies of long-term outcomes involved univariate analyses of
........................................................................................
Table XI Summary results of the meta-analyses of the
association between paternal factors and perinatal and
paediatric outcomes.
Exposure Outcome Pooled estimate
(with 95% CI)
Certainty of
evidence
GRADE
Paternal age PTB 1.02 (1.00–1.05) ⊕⊕○○
Low BW 1.00 (0.97–1.03) ⊕⊕○○
Stillbirth 1.19 (1.10–1.30) ⊕⊕○○
Children with any
birth defects
1.05 (1.02–1.07) ⊕⊕⊕○
CHDs 1.03 (0.99–1.06) ⊕⊕⊕○
Orofacial clefts 0.99 (0.95–1.04)
1.14 (1.02–1.29)*
⊕⊕○○
Gastroschisis 0.88 (0.78–1.00) ⊕⊕⊕○
Spina bifida 0.97 (0.90–1.04) ⊕⊕⊕○
Trisomy 21 1.13 (1.05–1.23) ⊕⊕⊕○
Acute
lymphoblastic
leukaemia
1.08 (0.96–1.21) ⊕⊕⊕○
Autism and ASDs 1.25 (1.20–1.30) ⊕⊕⊕○
Schizophrenia 1.31 (1.23–1.38) ⊕⊕⊕○
Paternal
BMI
No meta-analysis
Paternal
smoking
PTB 1.16 (1.00–1.35) ⊕⊕○○
Low BW 1.10 (1.00–1.21) ⊕⊕○○
SGA 1.22 (1.03–1.44) ⊕⊕○○
CHDs 1.75 (1.25–2.44) ⊕⊕○○
Orofacial clefts 1.51 (1.16–1.97) ⊕⊕○○
Brain tumours 1.12 (1.03–1.22) ⊕⊕○○
*Exposure: Paternal age >45 years.
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maternal smoking, and if not significant, the final results were not
adjusted for maternal smoking. Further differentiation between the
impact on long-term outcomes of paternal smoking in the preconcep-
tion stage, and during and after pregnancy, is a challenge. Exposure of
pregnant women to tobacco smoke in the environment may be a con-
founding factor and likewise, second-hand smoke after delivery is a
confounder when examining long-term outcomes.
Strengths and limitations
The major strength of this systematic review is the comprehensive lit-
erature search, identifying a huge number of relevant publications,
from the beginning of the 1950s up to 2017. Another strength is the
fact that it is possible to perform meta-analyses, making interpret-
ation of the summarized literature much easier for the reader. The
main limitation is the heterogeneity within the meta-analyses e.g. dif-
ferences in paternal age groups, reference groups, outcome measures
and statistical methods used in the studies included. This heterogen-
eity may, however, be of less importance since this systematic
review/meta-analysis is based solely on observational studies and not
on interventional trials. All estimates are thus limited to associations.
Another limitation which has to be observed is that most of the esti-
mates and 95% CI for the estimates are close to 1.00. Despite adjust-
ing for confounders, for example maternal age, residual confounders
might well exist, which could explain the association between pater-
nal age and several of the outcomes.
Conclusion
This systematic review and meta-analysis investigating paternal age,
smoking and BMI/weight/height as risk factors for adverse outcome
in offspring, found elevated risks for selected birth defects and psychi-
atric disorders as well as for selected cancers and metabolic distur-
bances. Although these risks represent serious health effects for the
children, the magnitude of these effects seems modest.
Supplementary data
Supplementary data are available at Human Reproduction Update
online.
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